US20090270705A1 - Automobile Physiological Monitoring System and Method for Using the Same - Google Patents
Automobile Physiological Monitoring System and Method for Using the Same Download PDFInfo
- Publication number
- US20090270705A1 US20090270705A1 US12/424,010 US42401009A US2009270705A1 US 20090270705 A1 US20090270705 A1 US 20090270705A1 US 42401009 A US42401009 A US 42401009A US 2009270705 A1 US2009270705 A1 US 2009270705A1
- Authority
- US
- United States
- Prior art keywords
- automobile
- user
- sensor
- monitoring system
- operating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1112—Global tracking of patients, e.g. by using GPS
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
- B60K28/00—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions
- B60K28/02—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver
- B60K28/06—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver
- B60K28/063—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver preventing starting of vehicles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
- B60K28/00—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions
- B60K28/02—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver
- B60K28/06—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver
- B60K28/066—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver actuating a signalling device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
- A61B2560/045—Modular apparatus with a separable interface unit, e.g. for communication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
Definitions
- Embodiments of the present invention are directed to sensor monitoring systems and methods. Specifically, embodiments of the present invention are directed to connecting sensor monitoring systems to automobile electronics capable of providing a nearest destination for a user to travel to based on sensor data.
- Diabetes is a disease in which the body does not produce or properly use insulin. Approximately 13 million people in the United States have been diagnosed with some form of diabetes. Type 1 diabetes results from the body's failure to produce insulin. Type 2 diabetes results from insulin resistance in which the body fails to properly use insulin. In order to effectively manage the disease, diabetics must closely monitor and manage their blood glucose levels through exercise, diet and medications. In particular, both Type 1 and Type 2 diabetics rely on insulin delivery and blood glucose monitoring to control their diabetes.
- External infusion devices have been used to deliver medication to a patient as generally described in U.S. Pat. Nos. 6,554,798 and 6,551,276, which are specifically incorporated by reference herein in their entireties.
- other medical devices have been used to determine body characteristics by obtaining a sample of bodily fluid.
- implantable electrochemical sensors have been developed for detecting and/or quantifying specific agents or compositions in a patient's blood.
- glucose sensors have been developed for use in obtaining an indication of blood glucose levels in a diabetic patient.
- Such readings can be especially useful in monitoring and/or adjusting a treatment regimen that typically includes the regular administration of insulin to the patient.
- blood glucose readings are particularly useful in improving medical therapies with semi-automated medication infusion pumps of the external type and/or implantable type.
- Newer systems deliver the preciseness of finger stick measurements coupled with the convenience of not having to repeatedly prick the skin to obtain glucose measurements. These newer systems provide the equivalent of over 200 finger stick readings per day. Additionally, continuous glucose monitoring systems allow physicians and patients to monitor blood glucose trends of their body and suggest and deliver insulin based on each patient's particular needs. Accordingly, physicians and medical device companies are always searching for more convenient ways to keep diabetic patients aware of their blood glucose levels throughout the day.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic.
- the at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile.
- the at least one user body characteristic is at least a glucose level of the user's body.
- At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile.
- Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile.
- the automobile electronics provide the sensor data to the user while the user is operating the automobile.
- a mobile telephone is operatively coupled to the automobile electronics.
- the automobile electronics initiate a communication via the mobile telephone based on the sensor data received from the at least one sensor.
- the sensor data received from the at least one sensor may indicate an emergency medical condition of the user.
- the mobile telephone may be operatively coupled to the automobile electronics via a wireless protocol.
- the communication initiated by the mobile telephone may be a voice call, a text message, or an e-mail.
- At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data.
- the at least one transmitter may communicate with the automobile electronics using at least one wireless protocol.
- the automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system.
- the automobile electronics may display sensor data to the user while the user is operating the automobile.
- the automobile electronics may include default high blood glucose and low blood glucose thresholds for the glucose level while the user is operating the automobile.
- the automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold.
- the automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the at least one alarm may provide at least one of audio, visual or tactile indications.
- the at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile.
- the automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile.
- the automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user.
- the automobile electronics may provide warnings of potential hypoglycemic or hyperglycemic situations while the user is operating the automobile.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic.
- the at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile.
- the at least one user body characteristic is at least a glucose level of the user's body.
- At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile.
- Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile.
- the automobile electronics provide the sensor data to the user while the user is operating the automobile.
- a global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user. The automobile electronics limit the user from operating the automobile to travel beyond a distance based on the sensor data received from the at least one sensor.
- GPS global positioning system
- the automobile electronics may provide a recommended destination before or at the distance for the user to travel to from the current location.
- the sensor data may include historical sensor data of the at least one user body characteristic.
- the sensor data received from the at least one sensor may indicate a hypoglycemic or a hyperglycemic condition of the user.
- the automobile electronics may permit the user to operate the automobile to travel beyond the distance to a second distance after making a stop before or at the distance.
- At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data.
- the at least one transmitter may communicate with the automobile electronics using at least one wireless protocol.
- the automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system.
- the automobile electronics may display sensor data to the user while the user is operating the automobile.
- the automobile electronics may include default high blood glucose and low blood glucose thresholds for the at least one glucose level while the user is operating the automobile.
- the automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold.
- the automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the at least one alarm may provide at least one of audio, visual or tactile indications.
- the at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile.
- the automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile.
- the automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user.
- the automobile electronics may provide warnings of potential hypoglycemic or hyperglycemic situations while the user is operating the automobile.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic.
- the at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile.
- the at least one user body characteristic is at least a glucose level of the user's body.
- At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile.
- Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile.
- the automobile electronics provide the sensor data to the user while the user is operating the automobile.
- a global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user.
- the automobile electronics provide a nearest destination from the current location of the user for the user to travel to based on the sensor data received from the at least one sensor.
- GPS global positioning system
- the nearest destination may be one of a hospital, a pharmacy, a medical office, a convenience store, a market, a rest stop, and a restaurant.
- At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data.
- the at least one transmitter may communicate with the automobile electronics using at least one wireless protocol.
- the automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system.
- the automobile electronics may display sensor data to the user while the user is operating the automobile.
- the automobile electronics may include default high blood glucose and low blood glucose thresholds for the glucose level while the user is operating the automobile.
- the automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold.
- the automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
- the at least one alarm may provide at least one of audio, visual or tactile indications.
- the at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile.
- the at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile.
- the automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile.
- the automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user.
- the sensor data received from the at least one sensor may indicate a hypoglycemic or a hyperglycemic condition of the user.
- FIG. 1 illustrates a continuous glucose monitoring system including a sensor, transmitter, and monitor.
- FIG. 2 illustrates an automobile monitoring system utilizing the glucose monitoring system of FIG. 1 according to embodiments of the present invention.
- FIG. 3 shows a block diagram of an automobile monitoring system according to embodiments of the present invention.
- FIG. 4 shows a block diagram of an automobile monitoring system according to embodiments of the present invention.
- FIG. 5 illustrates an automobile monitoring system utilizing the glucose monitoring system of FIG. 1 according to embodiments of the present invention.
- a real-time continuous glucose monitoring system communicates with electronics of an automobile to display real-time glucose sensor measurements and provide information related to high and low blood glucose levels to the patient in addition to blood glucose related trends using graphs and other analytical models.
- a real-time continuous glucose monitoring system communicates with electronics of an automobile to display real-time glucose sensor measurements and provide information related to high and low blood glucose levels to the patient in addition to blood glucose related trends using graphs and other analytical models.
- further embodiments of the invention may be used with other types of sensors to determine the levels of other agents, characteristics or compositions, such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads (e.g., HIV), heart rate, cardiac rhythm, or the like.
- a glucose monitoring system displays real-time glucose values to the patient.
- the glucose monitoring system includes a sensor 9 for measuring an agent such as blood glucose levels and the like.
- the sensor is a subcutaneously inserted electrochemical sensor that generates varying levels of electrical current proportional to the amount of glucose in a person's body. The current readings can then be translated into a blood glucose value that is understandable to a user.
- Example of such a sensor is described in U.S. Pat. No. 6,809,653 entitled, “Telemetered Characteristic Monitor System And Method Of Using The Same”, which is specifically incorporated by reference herein in its entirety.
- the sensor 9 includes a processing unit that translates the sensor readings into blood glucose readings.
- the processing unit is then linked to a transmitter 7 which would transmit the glucose values to a glucose monitor 5 that is capable of displaying the glucose values.
- the sensor and transmitter may be integrated into one unit or the sensor may have a built-in transmitter.
- the transmitter 7 provides the necessary electronics to communicate the sensor data to the glucose monitor 5 .
- the transmitter 7 attached to the sensor 9 may also serve as a receiver to receive data from the monitor 5 , a computer, an external infusion device or the like.
- Example of a sensor and transmitter combination may be found in commonly assigned U.S.
- the monitor 5 may include an LCD to display the sensor data.
- the monitor 5 may include an alarm and/or multiple alarms that activate when high and/or low blood glucose levels are detected. These alarms may be in the form of audible, visual, and/or tactile indications. In other embodiments, the alarms may activate upon user programmed instances such as an abnormal highs and/or lows in glucose levels for a particular time of the day.
- the glucose monitoring system may be adapted to communicate to automobile electronics.
- the sensor 9 and transmitter 7 communicate directly with automobile electronics 10 including GPS navigation system, DVD entertainment system, on-system computer, stereo system or the like.
- the automobile electronics may function as the traditional glucose monitor and display the sensor data to the patient on the dashboard, LCD screen located in the automobile, GPS navigation screen, DVD screen, stereo screen or the like.
- the automobile electronics may include algorithms to display sensor derived graphs and/or charts based on the patient's sensor data.
- the glucose sensor 20 and transmitter 30 may communicate directly with the glucose monitor 40 and/or the automobile electronics 50 as described above.
- the transmitter may communicate using wireless protocols such as Bluetooth, Infrared, Radio Frequency, 802.11a, 802.11b, 802.11g, or the like.
- the transmitter may be equipped to handle multiple communication protocols and/or a single communication protocol.
- the transmitter may communicate with the glucose monitor and or automobile electronics via a wired connection.
- the wire may either run from the transmitter into the glucose monitor and/or a port installed in the automobile's dashboard, GPS navigation system, DVD entertainment system, on-system computer, stereo system or the like.
- the wired port may use a standard computer connector port including serial, parallel, USB, FireWire (IEEE 1394), or the like.
- the glucose monitoring system may connect to the automobile electronics using any of the communication protocols described above.
- the sensor and transmitter may connect the moment the patient unlocks the automobile door, enters the automobile, places the key in the ignition or the like.
- algorithms may be in place that allow the automobile electronics to prevent ignition of the automobile if sensor data indicates glucose levels above and/or below particular threshold values.
- a warning may be displayed to the patient on the monitor itself and/or the automobile electronics notifying the user of high and/or low values.
- the automobile electronics may provide indications, data, graphs and/or trends on the dashboard, LCD screen located in the automobile, GPS navigation screen, DVD screen, stereo screen or the like.
- the automobile electronics may provide alarms based on factory and/or user specified occurrences. Examples include high blood glucose levels, low blood glucose levels and the like. The alarms may come in the form of audio, visual, and/or tactile indications.
- the glucose monitoring system may provide warnings and/or alarms to the patient while the patient is operating the automobile. These warnings and/or alarms may be based on high blood glucose readings, low blood glucose readings, or the like. In the event a warning and/or alarm is displayed to the patient while the automobile is in operation, the patient may be prompted to pull over the automobile and check the sensor readings prior to continued operation of the automobile.
- the safety factors associated with such a system provide diabetic patients and the public with advanced warnings of potential hypo- and/or hyper-glycemic situations.
- automobiles equipped with OnStarTM technology and/or any other similar communication protocols may transmit the sensor data to a central operational center.
- the transmitter 70 , monitor 80 and/or the automobile electronics 90 may communicate the sensor data to a central location 100 . These locations may be operational centers where an operator may assist the patient with any medical emergencies based on high and/or low blood glucose readings.
- the transmitter 70 , monitor 80 and/or automobile electronics 90 may transmit the sensor data to a specific medical center allowing selected physicians to monitor the sensor data, provide suggestions on treatment regimens, and/or assist the patient with overcoming dangerously high or low blood glucose levels.
- the OnStarTM technology may be utilized to contact the appropriate protective services based on dangerously high and/or low blood glucose readings. Paramedics, police and/or fire departments may be contacted depending on the severity of the situation.
- the transmitter, monitor and/or the automobile electronics may transmit the data to a central location using standardized wireless protocols including Wi-FiTM, GPS satellite, cellular network, or the like.
- FIG. 5 illustrates an automobile monitoring system utilizing the glucose monitoring system of FIG. 1 according to embodiments of the present invention.
- physiological monitoring systems such as glucose monitoring systems
- automobile electronics Such physiological systems include communication capabilities to relay physiological data to handheld monitors and/or automobile electronics.
- the connection allows physiological information to be displayed on electronics already residing in automobiles, including GPS systems, DVD systems, on-system computers, stereos, Bluetooth communication systems, and the like.
- Sensors may connect to different types of motorized vehicles including cars, boats, trucks, motorcycles, planes, and the like.
- the sensors may be attached to the body of a user to sense, for example, glucose levels in the bodily or interstitial fluids of the user while the user is operating the automobile.
- embodiments of the present invention are applicable to other types of medical devices, and are not limited to sensors. Examples of other medical devices include insulin infusion pumps, pacemakers, and the like.
- the monitoring systems may include predefined thresholds of physiological values.
- the monitoring system may be programmed with default high and low blood glucose thresholds for identifying hyperglycemic and/or hypoglycemic conditions. Based on these thresholds, the sensor monitoring system may utilize, for example, an automobile's Bluetooth communication system 10 to initiate a cellular telephone call through a paired cellular/mobile phone 3 , or similar communication device.
- a phone call may be placed to a caregiver, doctor, hospital, police, ambulance, or the like.
- a text message (SMS) or e-mail may be sent using the Bluetooth-paired cell phone 3 to a specific phone number or e-mail address. Any suitable communication protocols other than Bluetooth may be utilized, too.
- SMS text message
- Any suitable communication protocols other than Bluetooth may be utilized, too.
- the voice call, text message, and/or e-mail may be initiated, for example, when the sensor data indicates that the user is in, or is approaching, an emergency medical condition and may require immediate medical attention.
- program functions of medical devices with the user may be adjusted by the driver/user of the vehicle using the automobile's on-system computer 10 , i.e., Ford Motor Company's SYNCTM system.
- program functions may be adjusted by the sensor monitoring system's 9 handheld monitoring device/controller 5 (if included).
- program functions may be adjusted by either device or only one device.
- program functions may be adjusted by a central server (see, e.g., central operational center 100 in FIG. 4 above) that communicates with the automobile through a built-in GPS/safety system 10 , similar to the OnStarTM or BMW AssistTM systems.
- a medical device with the user may link up with the automobile on-system computer 10 (e.g., Ford's SYNCTM system) and utilize the on-system computer's 10 microphone, for example, for the user to issue voice commands to operate and control the medical device with the user.
- the automobile on-system computer 10 e.g., Ford's SYNCTM system
- the on-system computer's 10 microphone for example, for the user to issue voice commands to operate and control the medical device with the user.
- the medical device is an insulin infusion pump
- the user inside the car may issue a voice command through the on-system computer 10 to control and operate the insulin infusion pump (e.g., to deliver a bolus, display the status of the pump on the display screen of the on-system computer 10 , etc.)
- the on-system computer 10 has a communication device (e.g., a paired cellular/mobile phone 3 )
- the on-system computer 10 may receive calls from people remote from the user and the remote callers may also issue voice commands to operate and control the medical device with the user that is linked up with the on-system computer 10 .
- a Bluetooth (or any suitable protocol) headset may be paired with a medical device, e.g., an insulin infusion pump, and the user may also issue voice commands to the medical device via the headset.
- the on-system computer 10 has a communication interface (via cellular/mobile phone 3 , wireless modem, WiFi, GPS, radio, satellite, OnStarTM, etc.), others may also remotely access the medical device that is with the user linked up with the on-system computer 10 to control and operate the medical device, through for example, a Web site on the Internet, a PC, a mobile phone, or the like.
- a communication interface via cellular/mobile phone 3 , wireless modem, WiFi, GPS, radio, satellite, OnStarTM, etc.
- others may also remotely access the medical device that is with the user linked up with the on-system computer 10 to control and operate the medical device, through for example, a Web site on the Internet, a PC, a mobile phone, or the like.
- an automobile on-system computer 10 may control all functions of medical devices and/or physiological sensors 9 in the vicinity of the automobile.
- the physiological sensor 9 may not include a handheld monitor 5 for programming.
- the physiological sensor 9 may include a communication device to communicate (or pair) with an automobile on-system computer 10 , and all subsequent programming, control, and operation of the sensor 9 is handled by the automobile's computer system 10 .
- the senor may also include a handheld monitor 5 , where programming may take place by either a handheld monitor/controller 5 , the automobile on-system computer 10 , or by either device.
- communication between the physiological sensor 9 and the automobile electronics 10 may be handled through wireless means.
- no protocol conversion is necessary because the physiological sensor 9 includes the communication functionality that is already available in the vehicle.
- These embodiments include Bluetooth-like functionality (or similar standardized wireless protocols). If the sensor 9 includes Bluetooth capability, for example, the sensor 9 may communicate directly with the vehicle without the need for protocol conversion.
- the sensor 9 communicates directly with a USB receiver that receives data from the sensor 9 via a proprietary communication protocol.
- the USB receiver may plug directly into the automobile's on-system computer 10 to transfer data received from the physiological sensor 9 .
- the USB receiver functions as a wireless relay device by receiving data from a sensor 9 using a proprietary communication protocol, and then wirelessly sending the data to the automobile using, for example, standard Bluetooth connections.
- the USB receiver transfers the data directly through the USB connection on the automobile on-system computer 10 .
- a central server may include a patient's sensor history and may transmit to and display that data on the automobile's built-in display unit 10 (the navigation/GPS screen, the DVD screen, vehicle information screen, and the like).
- the central server may display blood glucose values from, for example, the past two weeks. Other time ranges may be available including the previous day extending all the way to previous years. Future predicted blood glucose values may also be displayed utilizing various blood glucose prediction algorithms and the like. Descriptions of systems utilizing predictive blood glucose algorithms may be found in U.S. Pat. No. 6,558,351 to Steil et al., entitled, “Closed Loop System for Controlling Insulin Infusion”, which is herein incorporated by reference in its entirety.
- the central server may operate, program, and control the sensor monitoring system 9 (or other nearby medical devices). In these embodiments, the central server may adjust settings on a device based on specific situations. Emergency control may be required if the driver of the automobile enters into a dangerous physical state based on readings received from the sensors 9 .
- the central server may be able to locate the patient in times of emergency situations—i.e., if the patient goes into a hypo- or hyperglycemic state and can no longer control the vehicle and/or respond to communications.
- the on-system computer 10 may prevent the driver from traveling beyond a certain distance from a hospital, home, or other location. These distance ranges and sensor thresholds may be programmed by the patient, the doctor, or by the central server.
- the automobile electronics 10 may provide a recommended destination that is before, or at, the maximum distance permitted for the user to drive based on at least one of the sensor data received from the sensor 9 , the user's current location, and the location of a particular establishment, such as a hospital, doctor's office, market/convenience store, the homes of the user/relatives/friends, restaurant, etc. Historical sensor data may be taken into account to determine the distance permitted for the user to drive.
- the automobile electronics 10 may permit the user to operate the automobile to travel beyond the maximum distance to a second distance after making a stop before or at the maximum distance (for example, making a “pit stop” for 15-minutes at a convenience store to take a break and buy some orange juice).
- Multiple waypoints with breaks/pit stops in between may permit a user to travel a long distance safely that would be otherwise not advisable for the user to undertake.
- the sensor readings may be uploaded directly to an online patient management tool (like Medtronic MiniMed's CareLink® system). Based on timing and patient readings, the automobile's on-system computer 10 may provide the patient with important information about his/her medical device usage. Some information may include a reminder to order additional medical supplies. In further embodiments, the system 10 may also recommend where to pick up the medical devices by locating the patient via the automobile's GPS system 12 .
- an online patient management tool like Medtronic MiniMed's CareLink® system.
- Internet connectivity may be built into the automobile, similar to GPS navigation integration.
- the driver of the vehicle may utilize an Internet connection available on a cellular/mobile phone 3 to upload/download information online.
- the cellular/mobile phone's 3 Internet connection may be tethered to the automobile electronics 10 for direct integration (i.e., via a Bluetooth connection).
- the monitoring system may use the GPS and/or Internet functionality to determine the location of the nearest hospital or restaurant.
- the GPS navigation system 12 may be utilized to locate the closest hospital, pharmacy, medical office, convenience store, market, rest stop, or restaurant, etc., so the patient can act immediately. For example, if the monitoring system determines that the user is experiencing a hypoglycemic condition, it may prompt the user to drive 0.3 miles down the same street to the next convenience store and purchase some orange juice, or the like.
- the monitoring system when connected to automobile electronics 10 —may allow potential drivers to obtain a drivers license.
- a person may not obtain a driver's license because they suffer from a disease like diabetes.
- the embodiments described in the present application may allow such individuals to obtain a driver's license because the automobile would only operate if the individual's monitored physiological characteristics were in normal ranges.
- a diabetic could operate the automobile so long as their blood glucose levels were in acceptable ranges as identified by their continuous glucose monitoring system, which is connected to the automobile electronics 10 .
- the on-system computer 10 may allow the patient to program the location and recommend pit stops based on the patient's blood glucose history.
- the system may analyze the patient's supplies, blood glucose history, and destination to recommend where the patient should stop and take a break.
- the patient may resume his/her journey after a period of time has lapsed. As discussed above, the patient may set up multiple waypoints (to take breaks, eat, etc.) to safely reach the ultimate destination.
- the monitoring system and automobile electronics 10 may include various alerts to identify specific conditions.
- a silent alert may activate and be transmitted to a central server. These silent alerts include a reminder that the patient needs to order new supplies, or may be simply a status check on how the monitoring system is functioning.
- specific conditions may be monitored based on predetermined doctor requests.
- the central server may review the received data and determine if additional action is necessary. If additional action is necessary, the central server may send a text message (SMS), or other communication, to the patient, a doctor, the vehicle, or caregiver.
- SMS text message
- the central server may require the automobile electronics 10 to display a message on the automobile's display unit and/or on the sensor's monitor 5 .
- standardized alerts may be displayed on the automobile electronics' 10 display units including high and low blood glucose levels and the like.
- other health conditions may be monitored in these systems including heart rate, levels of other agents, characteristics or compositions, such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Chemical & Material Sciences (AREA)
- Combustion & Propulsion (AREA)
- Transportation (AREA)
- Mechanical Engineering (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Radar, Positioning & Navigation (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic. The at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile. The at least one user body characteristic is at least a glucose level of the user's body. At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile. Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile. The automobile electronics provide the sensor data to the user while the user is operating the automobile. A global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user. The automobile electronics provide a nearest destination from the current location of the user for the user to travel to based on the sensor data received from the at least one sensor.
Description
- This application claims priority from U.S. Provisional App. No. 61/048,423, filed Apr. 28, 2008, which is herein incorporated by reference in its entirety.
- Embodiments of the present invention are directed to sensor monitoring systems and methods. Specifically, embodiments of the present invention are directed to connecting sensor monitoring systems to automobile electronics capable of providing a nearest destination for a user to travel to based on sensor data.
- Diabetes is a disease in which the body does not produce or properly use insulin. Approximately 13 million people in the United States have been diagnosed with some form of diabetes. Type 1 diabetes results from the body's failure to produce insulin. Type 2 diabetes results from insulin resistance in which the body fails to properly use insulin. In order to effectively manage the disease, diabetics must closely monitor and manage their blood glucose levels through exercise, diet and medications. In particular, both Type 1 and Type 2 diabetics rely on insulin delivery and blood glucose monitoring to control their diabetes.
- External infusion devices have been used to deliver medication to a patient as generally described in U.S. Pat. Nos. 6,554,798 and 6,551,276, which are specifically incorporated by reference herein in their entireties. In addition to delivering medication to a patient, other medical devices have been used to determine body characteristics by obtaining a sample of bodily fluid. A variety of implantable electrochemical sensors have been developed for detecting and/or quantifying specific agents or compositions in a patient's blood. For instance, glucose sensors have been developed for use in obtaining an indication of blood glucose levels in a diabetic patient. Such readings can be especially useful in monitoring and/or adjusting a treatment regimen that typically includes the regular administration of insulin to the patient. Thus, blood glucose readings are particularly useful in improving medical therapies with semi-automated medication infusion pumps of the external type and/or implantable type.
- Monitoring blood glucose levels plays an integral role in the management and control of diabetes. Finger stick measurements, glucose sensors, and monitors have traditionally been used to check the blood glucose levels of diabetic patients. In recent years, continuous glucose monitoring systems have been developed utilizing the latest sensor technologies incorporating both implantable and external sensors as generally described in U.S. Pat. No. 5,391,250 entitled, “Method of Fabricating Thin Film Sensors”, U.S. Pat. No. 6,484,046 entitled, “Electrochemical Analyte Sensor”, and U.S. Pat. Nos. 5,390,671, 5,568,806 and 5,586,553, entitled, “Transcutaneous Sensor Insertion Set”, all of which are specifically incorporated by reference herein in their entireties. Newer systems deliver the preciseness of finger stick measurements coupled with the convenience of not having to repeatedly prick the skin to obtain glucose measurements. These newer systems provide the equivalent of over 200 finger stick readings per day. Additionally, continuous glucose monitoring systems allow physicians and patients to monitor blood glucose trends of their body and suggest and deliver insulin based on each patient's particular needs. Accordingly, physicians and medical device companies are always searching for more convenient ways to keep diabetic patients aware of their blood glucose levels throughout the day.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic. The at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile. The at least one user body characteristic is at least a glucose level of the user's body. At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile. Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile. The automobile electronics provide the sensor data to the user while the user is operating the automobile. A mobile telephone is operatively coupled to the automobile electronics. The automobile electronics initiate a communication via the mobile telephone based on the sensor data received from the at least one sensor.
- The sensor data received from the at least one sensor may indicate an emergency medical condition of the user. The mobile telephone may be operatively coupled to the automobile electronics via a wireless protocol. The communication initiated by the mobile telephone may be a voice call, a text message, or an e-mail. At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data. The at least one transmitter may communicate with the automobile electronics using at least one wireless protocol. The automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system. Moreover, the automobile electronics may display sensor data to the user while the user is operating the automobile.
- The automobile electronics may include default high blood glucose and low blood glucose thresholds for the glucose level while the user is operating the automobile. The automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold. The automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The at least one alarm may provide at least one of audio, visual or tactile indications. The at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile. The automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile. The automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user. The automobile electronics may provide warnings of potential hypoglycemic or hyperglycemic situations while the user is operating the automobile.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic. The at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile. The at least one user body characteristic is at least a glucose level of the user's body. At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile. Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile. The automobile electronics provide the sensor data to the user while the user is operating the automobile. A global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user. The automobile electronics limit the user from operating the automobile to travel beyond a distance based on the sensor data received from the at least one sensor.
- The automobile electronics may provide a recommended destination before or at the distance for the user to travel to from the current location. The sensor data may include historical sensor data of the at least one user body characteristic. The sensor data received from the at least one sensor may indicate a hypoglycemic or a hyperglycemic condition of the user. The automobile electronics may permit the user to operate the automobile to travel beyond the distance to a second distance after making a stop before or at the distance. At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data. The at least one transmitter may communicate with the automobile electronics using at least one wireless protocol. The automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system. The automobile electronics may display sensor data to the user while the user is operating the automobile.
- The automobile electronics may include default high blood glucose and low blood glucose thresholds for the at least one glucose level while the user is operating the automobile. The automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold. The automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The at least one alarm may provide at least one of audio, visual or tactile indications. The at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile. The automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile. The automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user. The automobile electronics may provide warnings of potential hypoglycemic or hyperglycemic situations while the user is operating the automobile.
- An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic. The at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile. The at least one user body characteristic is at least a glucose level of the user's body. At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile. Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile. The automobile electronics provide the sensor data to the user while the user is operating the automobile. A global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user. The automobile electronics provide a nearest destination from the current location of the user for the user to travel to based on the sensor data received from the at least one sensor.
- The nearest destination may be one of a hospital, a pharmacy, a medical office, a convenience store, a market, a rest stop, and a restaurant. At least one monitor may be operatively coupled to the at least one transmitter to receive the sensor data. The at least one transmitter may communicate with the automobile electronics using at least one wireless protocol. The automobile electronics may include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system. The automobile electronics may display sensor data to the user while the user is operating the automobile.
- The automobile electronics may include default high blood glucose and low blood glucose thresholds for the glucose level while the user is operating the automobile. The automobile electronics may prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold. The automobile electronics may provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The automobile electronics may sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile. The at least one alarm may provide at least one of audio, visual or tactile indications. The at least one sensor may be attached to the body of the user to sense the glucose level in bodily and/or interstitial fluids of the user while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile. The at least one sensor may be attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile. The automobile electronics may provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile. The automobile electronics may include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user. The sensor data received from the at least one sensor may indicate a hypoglycemic or a hyperglycemic condition of the user.
-
FIG. 1 illustrates a continuous glucose monitoring system including a sensor, transmitter, and monitor. -
FIG. 2 illustrates an automobile monitoring system utilizing the glucose monitoring system ofFIG. 1 according to embodiments of the present invention. -
FIG. 3 shows a block diagram of an automobile monitoring system according to embodiments of the present invention. -
FIG. 4 shows a block diagram of an automobile monitoring system according to embodiments of the present invention. -
FIG. 5 illustrates an automobile monitoring system utilizing the glucose monitoring system ofFIG. 1 according to embodiments of the present invention. - As shown in the drawings for purposes of illustration, the invention is embodied in a glucose monitoring system for use with an automobile vehicle. In particular embodiments of the invention, a real-time continuous glucose monitoring system communicates with electronics of an automobile to display real-time glucose sensor measurements and provide information related to high and low blood glucose levels to the patient in addition to blood glucose related trends using graphs and other analytical models. It will be recognized that further embodiments of the invention may be used with other types of sensors to determine the levels of other agents, characteristics or compositions, such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads (e.g., HIV), heart rate, cardiac rhythm, or the like.
- In particular embodiments of the invention, a glucose monitoring system, as shown in
FIG. 1 , displays real-time glucose values to the patient. In these embodiments, the glucose monitoring system includes asensor 9 for measuring an agent such as blood glucose levels and the like. In preferred embodiments, the sensor is a subcutaneously inserted electrochemical sensor that generates varying levels of electrical current proportional to the amount of glucose in a person's body. The current readings can then be translated into a blood glucose value that is understandable to a user. Example of such a sensor is described in U.S. Pat. No. 6,809,653 entitled, “Telemetered Characteristic Monitor System And Method Of Using The Same”, which is specifically incorporated by reference herein in its entirety. However, any type of glucose sensor that can produce a glucose value would work with the system described inFIG. 1 . In preferred embodiments, thesensor 9 includes a processing unit that translates the sensor readings into blood glucose readings. The processing unit is then linked to atransmitter 7 which would transmit the glucose values to aglucose monitor 5 that is capable of displaying the glucose values. In certain embodiments, the sensor and transmitter may be integrated into one unit or the sensor may have a built-in transmitter. Thetransmitter 7 provides the necessary electronics to communicate the sensor data to theglucose monitor 5. In still further embodiments, thetransmitter 7 attached to thesensor 9 may also serve as a receiver to receive data from themonitor 5, a computer, an external infusion device or the like. Example of a sensor and transmitter combination may be found in commonly assigned U.S. patent application Ser. No. 12/056,651 entitled “Glucose Sensor Transceiver”, which is specifically incorporated by reference herein in its entirety. - The
monitor 5 may include an LCD to display the sensor data. In other embodiments, themonitor 5 may include an alarm and/or multiple alarms that activate when high and/or low blood glucose levels are detected. These alarms may be in the form of audible, visual, and/or tactile indications. In other embodiments, the alarms may activate upon user programmed instances such as an abnormal highs and/or lows in glucose levels for a particular time of the day. - In other embodiments, the glucose monitoring system may be adapted to communicate to automobile electronics. In particular embodiments, as shown in
FIG. 2 , thesensor 9 andtransmitter 7 communicate directly withautomobile electronics 10 including GPS navigation system, DVD entertainment system, on-system computer, stereo system or the like. In these embodiments, the automobile electronics may function as the traditional glucose monitor and display the sensor data to the patient on the dashboard, LCD screen located in the automobile, GPS navigation screen, DVD screen, stereo screen or the like. In additional embodiments, the automobile electronics may include algorithms to display sensor derived graphs and/or charts based on the patient's sensor data. - In further embodiments, as shown in
FIG. 3 , theglucose sensor 20 andtransmitter 30 may communicate directly with the glucose monitor 40 and/or theautomobile electronics 50 as described above. In particular embodiments, the transmitter may communicate using wireless protocols such as Bluetooth, Infrared, Radio Frequency, 802.11a, 802.11b, 802.11g, or the like. The transmitter may be equipped to handle multiple communication protocols and/or a single communication protocol. In still additional embodiments, the transmitter may communicate with the glucose monitor and or automobile electronics via a wired connection. The wire may either run from the transmitter into the glucose monitor and/or a port installed in the automobile's dashboard, GPS navigation system, DVD entertainment system, on-system computer, stereo system or the like. The wired port may use a standard computer connector port including serial, parallel, USB, FireWire (IEEE 1394), or the like. - In additional embodiments, the glucose monitoring system may connect to the automobile electronics using any of the communication protocols described above. In these embodiments, the sensor and transmitter may connect the moment the patient unlocks the automobile door, enters the automobile, places the key in the ignition or the like. Upon connection, algorithms may be in place that allow the automobile electronics to prevent ignition of the automobile if sensor data indicates glucose levels above and/or below particular threshold values. Alternatively, in other embodiments, a warning may be displayed to the patient on the monitor itself and/or the automobile electronics notifying the user of high and/or low values.
- In other embodiments, the automobile electronics may provide indications, data, graphs and/or trends on the dashboard, LCD screen located in the automobile, GPS navigation screen, DVD screen, stereo screen or the like. In alternative embodiments, the automobile electronics may provide alarms based on factory and/or user specified occurrences. Examples include high blood glucose levels, low blood glucose levels and the like. The alarms may come in the form of audio, visual, and/or tactile indications.
- In other embodiments, the glucose monitoring system may provide warnings and/or alarms to the patient while the patient is operating the automobile. These warnings and/or alarms may be based on high blood glucose readings, low blood glucose readings, or the like. In the event a warning and/or alarm is displayed to the patient while the automobile is in operation, the patient may be prompted to pull over the automobile and check the sensor readings prior to continued operation of the automobile. The safety factors associated with such a system provide diabetic patients and the public with advanced warnings of potential hypo- and/or hyper-glycemic situations.
- In still further alternative embodiments, as shown in
FIG. 4 , automobiles equipped with OnStar™ technology and/or any other similar communication protocols may transmit the sensor data to a central operational center. In particular, thetransmitter 70, monitor 80 and/or theautomobile electronics 90 may communicate the sensor data to acentral location 100. These locations may be operational centers where an operator may assist the patient with any medical emergencies based on high and/or low blood glucose readings. In further embodiments, thetransmitter 70, monitor 80 and/orautomobile electronics 90 may transmit the sensor data to a specific medical center allowing selected physicians to monitor the sensor data, provide suggestions on treatment regimens, and/or assist the patient with overcoming dangerously high or low blood glucose levels. In still additional embodiments, the OnStar™ technology may be utilized to contact the appropriate protective services based on dangerously high and/or low blood glucose readings. Paramedics, police and/or fire departments may be contacted depending on the severity of the situation. - In further embodiments, for vehicles not equipped with OnStar™ type technology, the transmitter, monitor and/or the automobile electronics may transmit the data to a central location using standardized wireless protocols including Wi-Fi™, GPS satellite, cellular network, or the like.
- An illustrative automobile monitoring system is described in U.S. Pat. App. No. 2007/0112261, published May 17, 2007, to Enegren et al., and is entitled, “Automobile Glucose Sensor Monitoring System and Method for Using the Same”, which is herein incorporated by reference in its entirety.
-
FIG. 5 illustrates an automobile monitoring system utilizing the glucose monitoring system ofFIG. 1 according to embodiments of the present invention. According to embodiments of the present invention, physiological monitoring systems, such as glucose monitoring systems, are connected to automobile electronics. Such physiological systems include communication capabilities to relay physiological data to handheld monitors and/or automobile electronics. The connection allows physiological information to be displayed on electronics already residing in automobiles, including GPS systems, DVD systems, on-system computers, stereos, Bluetooth communication systems, and the like. Sensors may connect to different types of motorized vehicles including cars, boats, trucks, motorcycles, planes, and the like. The sensors may be attached to the body of a user to sense, for example, glucose levels in the bodily or interstitial fluids of the user while the user is operating the automobile. In addition, embodiments of the present invention are applicable to other types of medical devices, and are not limited to sensors. Examples of other medical devices include insulin infusion pumps, pacemakers, and the like. - According to embodiments of the present invention, the monitoring systems may include predefined thresholds of physiological values. The monitoring system, for example, may be programmed with default high and low blood glucose thresholds for identifying hyperglycemic and/or hypoglycemic conditions. Based on these thresholds, the sensor monitoring system may utilize, for example, an automobile's
Bluetooth communication system 10 to initiate a cellular telephone call through a paired cellular/mobile phone 3, or similar communication device. A phone call may be placed to a caregiver, doctor, hospital, police, ambulance, or the like. According to embodiments of the present invention, a text message (SMS) or e-mail may be sent using the Bluetooth-pairedcell phone 3 to a specific phone number or e-mail address. Any suitable communication protocols other than Bluetooth may be utilized, too. The voice call, text message, and/or e-mail may be initiated, for example, when the sensor data indicates that the user is in, or is approaching, an emergency medical condition and may require immediate medical attention. - Moreover, according to embodiments of the present invention, program functions of medical devices with the user, for example, monitoring systems such as
glucose sensor systems 9, may be adjusted by the driver/user of the vehicle using the automobile's on-system computer 10, i.e., Ford Motor Company's SYNC™ system. Alternatively, program functions may be adjusted by the sensor monitoring system's 9 handheld monitoring device/controller 5 (if included). In other embodiments, program functions may be adjusted by either device or only one device. In still other embodiments, program functions may be adjusted by a central server (see, e.g., centraloperational center 100 inFIG. 4 above) that communicates with the automobile through a built-in GPS/safety system 10, similar to the OnStar™ or BMW Assist™ systems. - According to embodiments of the present invention, a medical device with the user, for example, a
glucose sensor system 9, may link up with the automobile on-system computer 10 (e.g., Ford's SYNC™ system) and utilize the on-system computer's 10 microphone, for example, for the user to issue voice commands to operate and control the medical device with the user. For example, if the medical device is an insulin infusion pump, the user inside the car (be it the driver or passenger) may issue a voice command through the on-system computer 10 to control and operate the insulin infusion pump (e.g., to deliver a bolus, display the status of the pump on the display screen of the on-system computer 10, etc.) Additionally, if the on-system computer 10 has a communication device (e.g., a paired cellular/mobile phone 3), the on-system computer 10 may receive calls from people remote from the user and the remote callers may also issue voice commands to operate and control the medical device with the user that is linked up with the on-system computer 10. Alternatively, a Bluetooth (or any suitable protocol) headset may be paired with a medical device, e.g., an insulin infusion pump, and the user may also issue voice commands to the medical device via the headset. - Moreover, if the on-
system computer 10 has a communication interface (via cellular/mobile phone 3, wireless modem, WiFi, GPS, radio, satellite, OnStar™, etc.), others may also remotely access the medical device that is with the user linked up with the on-system computer 10 to control and operate the medical device, through for example, a Web site on the Internet, a PC, a mobile phone, or the like. - According to embodiments of the present invention, an automobile on-system computer 10 (e.g., Ford's SYNC™ system) may control all functions of medical devices and/or
physiological sensors 9 in the vicinity of the automobile. In these embodiments, thephysiological sensor 9 may not include ahandheld monitor 5 for programming. Instead, thephysiological sensor 9 may include a communication device to communicate (or pair) with an automobile on-system computer 10, and all subsequent programming, control, and operation of thesensor 9 is handled by the automobile'scomputer system 10. - In still further embodiments, the sensor may also include a
handheld monitor 5, where programming may take place by either a handheld monitor/controller 5, the automobile on-system computer 10, or by either device. - In some embodiments, communication between the
physiological sensor 9 and theautomobile electronics 10 may be handled through wireless means. In particular embodiments, no protocol conversion is necessary because thephysiological sensor 9 includes the communication functionality that is already available in the vehicle. These embodiments include Bluetooth-like functionality (or similar standardized wireless protocols). If thesensor 9 includes Bluetooth capability, for example, thesensor 9 may communicate directly with the vehicle without the need for protocol conversion. - In other embodiments, the
sensor 9 communicates directly with a USB receiver that receives data from thesensor 9 via a proprietary communication protocol. The USB receiver may plug directly into the automobile's on-system computer 10 to transfer data received from thephysiological sensor 9. In some embodiments, the USB receiver functions as a wireless relay device by receiving data from asensor 9 using a proprietary communication protocol, and then wirelessly sending the data to the automobile using, for example, standard Bluetooth connections. In other embodiments, the USB receiver transfers the data directly through the USB connection on the automobile on-system computer 10. - In some embodiments, a central server (see, e.g., central
operational center 100 inFIG. 4 above) may include a patient's sensor history and may transmit to and display that data on the automobile's built-in display unit 10 (the navigation/GPS screen, the DVD screen, vehicle information screen, and the like). In the case of aglucose sensor 9, the central server may display blood glucose values from, for example, the past two weeks. Other time ranges may be available including the previous day extending all the way to previous years. Future predicted blood glucose values may also be displayed utilizing various blood glucose prediction algorithms and the like. Descriptions of systems utilizing predictive blood glucose algorithms may be found in U.S. Pat. No. 6,558,351 to Steil et al., entitled, “Closed Loop System for Controlling Insulin Infusion”, which is herein incorporated by reference in its entirety. - In other embodiments, the central server may operate, program, and control the sensor monitoring system 9 (or other nearby medical devices). In these embodiments, the central server may adjust settings on a device based on specific situations. Emergency control may be required if the driver of the automobile enters into a dangerous physical state based on readings received from the
sensors 9. - In some embodiments, if the automobile includes a
GPS navigation system 12, the central server may be able to locate the patient in times of emergency situations—i.e., if the patient goes into a hypo- or hyperglycemic state and can no longer control the vehicle and/or respond to communications. In other instances, if a patient tends to go hypoglycemic, the on-system computer 10 may prevent the driver from traveling beyond a certain distance from a hospital, home, or other location. These distance ranges and sensor thresholds may be programmed by the patient, the doctor, or by the central server. According to embodiments of the present invention, theautomobile electronics 10 may provide a recommended destination that is before, or at, the maximum distance permitted for the user to drive based on at least one of the sensor data received from thesensor 9, the user's current location, and the location of a particular establishment, such as a hospital, doctor's office, market/convenience store, the homes of the user/relatives/friends, restaurant, etc. Historical sensor data may be taken into account to determine the distance permitted for the user to drive. According to alternative embodiments of the present invention, theautomobile electronics 10 may permit the user to operate the automobile to travel beyond the maximum distance to a second distance after making a stop before or at the maximum distance (for example, making a “pit stop” for 15-minutes at a convenience store to take a break and buy some orange juice). Multiple waypoints with breaks/pit stops in between may permit a user to travel a long distance safely that would be otherwise not advisable for the user to undertake. - In other embodiments, if the automobile also includes Internet connectivity, the sensor readings may be uploaded directly to an online patient management tool (like Medtronic MiniMed's CareLink® system). Based on timing and patient readings, the automobile's on-
system computer 10 may provide the patient with important information about his/her medical device usage. Some information may include a reminder to order additional medical supplies. In further embodiments, thesystem 10 may also recommend where to pick up the medical devices by locating the patient via the automobile'sGPS system 12. - Internet connectivity may be built into the automobile, similar to GPS navigation integration. Alternatively, the driver of the vehicle may utilize an Internet connection available on a cellular/
mobile phone 3 to upload/download information online. In still other embodiments, the cellular/mobile phone's 3 Internet connection may be tethered to theautomobile electronics 10 for direct integration (i.e., via a Bluetooth connection). - In further embodiments, the monitoring system may use the GPS and/or Internet functionality to determine the location of the nearest hospital or restaurant. In the case of a diabetic patient, if the monitoring system senses that the patient needs additional insulin (hyperglycemic) or needs additional carbohydrates (hypoglycemic), or has a medical or non-medical condition requiring attention, the
GPS navigation system 12 may be utilized to locate the closest hospital, pharmacy, medical office, convenience store, market, rest stop, or restaurant, etc., so the patient can act immediately. For example, if the monitoring system determines that the user is experiencing a hypoglycemic condition, it may prompt the user to drive 0.3 miles down the same street to the next convenience store and purchase some orange juice, or the like. - In other embodiments of the invention, the monitoring system—when connected to
automobile electronics 10—may allow potential drivers to obtain a drivers license. In some countries, for example, a person may not obtain a driver's license because they suffer from a disease like diabetes. In such countries, the embodiments described in the present application may allow such individuals to obtain a driver's license because the automobile would only operate if the individual's monitored physiological characteristics were in normal ranges. As an example, a diabetic could operate the automobile so long as their blood glucose levels were in acceptable ranges as identified by their continuous glucose monitoring system, which is connected to theautomobile electronics 10. - In other embodiments, if the driver of the automobile were to undertake a long drive, the on-
system computer 10 may allow the patient to program the location and recommend pit stops based on the patient's blood glucose history. The system may analyze the patient's supplies, blood glucose history, and destination to recommend where the patient should stop and take a break. The patient may resume his/her journey after a period of time has lapsed. As discussed above, the patient may set up multiple waypoints (to take breaks, eat, etc.) to safely reach the ultimate destination. - In further embodiments, the monitoring system and
automobile electronics 10 may include various alerts to identify specific conditions. In some embodiments, a silent alert may activate and be transmitted to a central server. These silent alerts include a reminder that the patient needs to order new supplies, or may be simply a status check on how the monitoring system is functioning. In other embodiments, specific conditions may be monitored based on predetermined doctor requests. Upon receipt of the silent alerts, the central server may review the received data and determine if additional action is necessary. If additional action is necessary, the central server may send a text message (SMS), or other communication, to the patient, a doctor, the vehicle, or caregiver. In other embodiments, the central server may require theautomobile electronics 10 to display a message on the automobile's display unit and/or on the sensor'smonitor 5. - In still further embodiments, standardized alerts may be displayed on the automobile electronics' 10 display units including high and low blood glucose levels and the like. Again, other health conditions may be monitored in these systems including heart rate, levels of other agents, characteristics or compositions, such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads and the like.
- While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
- The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (17)
1. An automobile monitoring system to monitor user body characteristics, comprising:
at least one sensor to monitor at least one user body characteristic, wherein the at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile, and the at least one user body characteristic is at least a glucose level of the user's body;
at least one transmitter operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile;
automobile electronics operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile, wherein the automobile electronics provide the sensor data to the user while the user is operating the automobile; and
a global positioning system (GPS) operatively coupled to the automobile electronics to determine a current location of the user, wherein the automobile electronics provide a nearest destination from the current location of the user for the user to travel to based on the sensor data received from the at least one sensor.
2. The automobile monitoring system of claim 1 , wherein the nearest destination is selected from the group consisting of: a hospital, a pharmacy, a medical office, a convenience store, a market, a rest stop, and a restaurant.
3. The automobile monitoring system of claim 1 , further including:
at least one monitor operatively coupled to the at least one transmitter to receive the sensor data.
4. The automobile monitoring system of claim 1 , wherein the at least one transmitter communicates with the automobile electronics using at least one wireless protocol.
5. The automobile monitoring system of claim 1 , wherein the automobile electronics include at least one of a GPS navigation system, a DVD entertainment system, an on-system computer, or a stereo system, and wherein the automobile electronics display sensor data to the user while the user is operating the automobile.
6. The automobile monitoring system of claim 1 , wherein the automobile electronics include default high blood glucose and low blood glucose thresholds for the glucose level while the user is operating the automobile.
7. The automobile monitoring system of claim 6 , wherein the automobile electronics further prevent ignition of the automobile when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold.
8. The automobile monitoring system of claim 6 , wherein the automobile electronics provide at least one warning when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
9. The automobile monitoring system of claim 6 , wherein the automobile electronics sound at least one alarm when the sensor data is above the high blood glucose threshold or below the low blood glucose threshold while the user is operating the automobile.
10. The automobile monitoring system of claim 9 , wherein the at least one alarm provides at least one of audio, visual or tactile indications.
11. The automobile monitoring system of claim 1 , wherein the at least one sensor is attached to the body of the user to sense the glucose level in bodily fluids of the user while the user is operating the automobile.
12. The automobile monitoring system of claim 1 , wherein the at least one sensor is attached to the body of the user to sense the glucose level in interstitial fluid contained in the body of the user while the user is operating the automobile.
13. The automobile monitoring system of claim 1 , wherein the at least one sensor is attached to the body of the user to sense the glucose level on either a continuous, near continuous, or intermittent basis while the user is operating the automobile.
14. The automobile monitoring system of claim 1 , wherein the at least one sensor is attached to the body of the user to sense the glucose level on a real-time basis while the user is operating the automobile.
15. The automobile monitoring system of claim 1 , wherein the automobile electronics provide a warning to the user, while the automobile is in operation, to pull over the automobile and check the sensor readings prior to continued operation of the automobile.
16. The automobile monitoring system of claim 1 , wherein the automobile electronics further include the ability to access a communication technology that can send sensor data to an operational center to obtain assistance for the user.
17. The automobile monitoring system of claim 1 , wherein the sensor data received from the at least one sensor indicates a hypoglycemic or a hyperglycemic condition of the user.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/424,010 US20090270705A1 (en) | 2008-04-28 | 2009-04-15 | Automobile Physiological Monitoring System and Method for Using the Same |
EP09739424.1A EP2278910B8 (en) | 2008-04-28 | 2009-04-16 | Automobile physiological monitoring system |
PCT/US2009/040772 WO2009134622A1 (en) | 2008-04-28 | 2009-04-16 | Automobile physiological monitoring system and method for using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4842308P | 2008-04-28 | 2008-04-28 | |
US12/424,010 US20090270705A1 (en) | 2008-04-28 | 2009-04-15 | Automobile Physiological Monitoring System and Method for Using the Same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090270705A1 true US20090270705A1 (en) | 2009-10-29 |
Family
ID=41214459
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/423,964 Active 2030-07-09 US8207859B2 (en) | 2008-04-28 | 2009-04-15 | Automobile physiological monitoring system and method for using the same |
US12/424,010 Abandoned US20090270705A1 (en) | 2008-04-28 | 2009-04-15 | Automobile Physiological Monitoring System and Method for Using the Same |
US12/423,976 Active 2030-07-09 US8207860B2 (en) | 2008-04-28 | 2009-04-15 | Automobile physiological monitoring system and method for using the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/423,964 Active 2030-07-09 US8207859B2 (en) | 2008-04-28 | 2009-04-15 | Automobile physiological monitoring system and method for using the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/423,976 Active 2030-07-09 US8207860B2 (en) | 2008-04-28 | 2009-04-15 | Automobile physiological monitoring system and method for using the same |
Country Status (3)
Country | Link |
---|---|
US (3) | US8207859B2 (en) |
EP (1) | EP2278910B8 (en) |
WO (1) | WO2009134622A1 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110178382A1 (en) * | 2010-01-19 | 2011-07-21 | Topp Claire H | Blood glucose ignition interlock |
US20120059227A1 (en) * | 2010-09-03 | 2012-03-08 | International Business Machines Corporation | Directing a user to a medical resource |
US8287495B2 (en) | 2009-07-30 | 2012-10-16 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US8718949B2 (en) | 2008-01-07 | 2014-05-06 | Tandem Diabetes Care, Inc. | Insulin pump with blood glucose modules |
US20140179256A1 (en) * | 2010-11-08 | 2014-06-26 | Ford Global Technologies, Llc | Vehicle System Reaction to Medical Conditions |
US9164801B2 (en) | 2010-06-08 | 2015-10-20 | International Business Machines Corporation | Probabilistic optimization of resource discovery, reservation and assignment |
US9292577B2 (en) | 2010-09-17 | 2016-03-22 | International Business Machines Corporation | User accessibility to data analytics |
US9299238B1 (en) * | 2014-07-23 | 2016-03-29 | Invoy Technologies, Llc | Ketone measurement system capable of detecting and notifying a user of proper insertion of detachable components |
US20160138492A1 (en) * | 2014-11-13 | 2016-05-19 | Infineon Technologies Ag | Reduced Power Consumption with Sensors Transmitting Data Using Current Modulation |
US9474856B2 (en) | 2007-05-24 | 2016-10-25 | Tandem Diabetes Care, Inc. | Expert system for infusion pump therapy |
US9486169B1 (en) | 2014-04-18 | 2016-11-08 | Invoy Technologies, Llc | Ketone measurement system and related method with accuracy and reporting enhancement features |
US20170035296A1 (en) * | 2010-03-15 | 2017-02-09 | Welch Allyn, Inc. | Personal Area Network Pairing |
US20170068438A1 (en) * | 2011-11-16 | 2017-03-09 | Autoconnect Holdings Llc | Gesture recognition for on-board display |
US9599986B1 (en) * | 2015-12-22 | 2017-03-21 | International Business Machines Corporation | Emergency automated vehicle control system to monitor emergency medical events through body area networks |
US9646271B2 (en) | 2010-08-06 | 2017-05-09 | International Business Machines Corporation | Generating candidate inclusion/exclusion cohorts for a multiply constrained group |
US9669160B2 (en) | 2014-07-30 | 2017-06-06 | Tandem Diabetes Care, Inc. | Temporary suspension for closed-loop medicament therapy |
US20170181630A1 (en) * | 2015-12-28 | 2017-06-29 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
US9833177B2 (en) | 2007-05-30 | 2017-12-05 | Tandem Diabetes Care, Inc. | Insulin pump based expert system |
US9962486B2 (en) | 2013-03-14 | 2018-05-08 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10016559B2 (en) | 2009-12-04 | 2018-07-10 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
US10258736B2 (en) | 2012-05-17 | 2019-04-16 | Tandem Diabetes Care, Inc. | Systems including vial adapter for fluid transfer |
US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
US10583842B1 (en) * | 2018-08-31 | 2020-03-10 | Toyota Motor Engineering & Manufacturing North America, Inc. | Driver state detection based on glycemic condition |
US10860687B2 (en) | 2012-12-31 | 2020-12-08 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10861308B1 (en) * | 2019-05-29 | 2020-12-08 | Siemens Industry, Inc. | System and method to improve emergency response time |
US10856736B2 (en) | 2012-12-31 | 2020-12-08 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10864322B2 (en) | 2013-09-06 | 2020-12-15 | Tandem Diabetes Care, Inc. | System and method for mitigating risk in automated medicament dosing |
US10888655B2 (en) | 2019-02-19 | 2021-01-12 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US11291763B2 (en) | 2007-03-13 | 2022-04-05 | Tandem Diabetes Care, Inc. | Basal rate testing using frequent blood glucose input |
US11305057B2 (en) | 2019-03-26 | 2022-04-19 | Tandem Diabetes Care, Inc. | Method and system of operating an infusion pump with a remote control device |
WO2022235666A1 (en) * | 2021-05-03 | 2022-11-10 | Mindset Medical, Inc. | Server, systems and methods for automating safety actions using monitored parameters |
US11676694B2 (en) | 2012-06-07 | 2023-06-13 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
GB2617105A (en) * | 2022-03-29 | 2023-10-04 | Jaguar Land Rover Ltd | In-vehicle blood glucose level monitoring |
Families Citing this family (242)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6694191B2 (en) | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US8152789B2 (en) | 2001-10-23 | 2012-04-10 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US10080529B2 (en) | 2001-12-27 | 2018-09-25 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US9339217B2 (en) | 2011-11-25 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US9056165B2 (en) | 2006-09-06 | 2015-06-16 | Medtronic Minimed, Inc. | Intelligent therapy recommendation algorithm and method of using the same |
EP2120680A2 (en) | 2007-02-06 | 2009-11-25 | Glumetrics, Inc. | Optical systems and methods for rationmetric measurement of blood glucose concentration |
EP2162057A1 (en) | 2007-05-10 | 2010-03-17 | Glumetrics, Inc. | Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement |
DE102007023728A1 (en) * | 2007-05-22 | 2008-11-27 | Ford Global Technologies, LLC, Dearborn | Method and device for electronic communication between at least two communication devices |
US8700114B2 (en) | 2008-07-31 | 2014-04-15 | Medtronic Minmed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US20100268051A1 (en) * | 2009-04-16 | 2010-10-21 | Ford Global Technologies, Llc | System and method for wellness monitoring in a vehicle |
FI4070729T3 (en) | 2009-08-31 | 2024-06-04 | Abbott Diabetes Care Inc | Displays for a medical device |
US8070723B2 (en) | 2009-12-31 | 2011-12-06 | Medtronic Minimed, Inc. | Activity guard |
US20110225228A1 (en) * | 2010-03-11 | 2011-09-15 | Ford Global Technologies, Llc | Method and systems for queuing messages for vehicle-related services |
US9215995B2 (en) | 2010-06-23 | 2015-12-22 | Medtronic Minimed, Inc. | Sensor systems having multiple probes and electrode arrays |
US20120039248A1 (en) * | 2010-08-10 | 2012-02-16 | Ford Global Technologies, Llc | Method and system for in-vehicle wireless connectivity |
US8718632B2 (en) | 2010-08-26 | 2014-05-06 | Ford Global Technologies, Llc | Service delivery network |
US8628510B2 (en) | 2010-12-22 | 2014-01-14 | Medtronic Minimed, Inc. | Monitoring the operating health of a force sensor in a fluid infusion device |
US9135466B2 (en) | 2010-12-30 | 2015-09-15 | Telefonaktiebolaget L M Ericsson (Publ) | Biometric user equipment GUI trigger |
US8900206B2 (en) | 2011-02-22 | 2014-12-02 | Medtronic Minimed, Inc. | Pressure vented fluid reservoir for a fluid infusion device |
US11266823B2 (en) | 2011-02-22 | 2022-03-08 | Medtronic Minimed, Inc. | Retractable sealing assembly for a fluid reservoir of a fluid infusion device |
US8831817B2 (en) | 2011-03-07 | 2014-09-09 | Ford Global Technologies, Llc | Methods and apparatus for lost connection handling |
US9008744B2 (en) | 2011-05-06 | 2015-04-14 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
US8795231B2 (en) | 2011-05-10 | 2014-08-05 | Medtronic Minimed, Inc. | Automated reservoir fill system |
CA2850148C (en) | 2011-09-27 | 2020-02-25 | Glumetrics, Inc. | Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrombogenic agent |
US9989522B2 (en) | 2011-11-01 | 2018-06-05 | Medtronic Minimed, Inc. | Methods and materials for modulating start-up time and air removal in dry sensors |
US8999720B2 (en) | 2011-11-17 | 2015-04-07 | Medtronic Minimed, Inc. | Aqueous radiation protecting formulations and methods for making and using them |
US9610401B2 (en) | 2012-01-13 | 2017-04-04 | Medtronic Minimed, Inc. | Infusion set component with modular fluid channel element |
US9010477B2 (en) | 2012-02-16 | 2015-04-21 | Aonec, Llc | In vehicle glucose apparatus and vehicular operation inhibitor |
US9493807B2 (en) | 2012-05-25 | 2016-11-15 | Medtronic Minimed, Inc. | Foldover sensors and methods for making and using them |
US9213010B2 (en) | 2012-06-08 | 2015-12-15 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
US9682188B2 (en) | 2012-08-21 | 2017-06-20 | Medtronic Minimed, Inc. | Reservoir fluid volume estimator and medical device incorporating same |
US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
US10130767B2 (en) | 2012-08-30 | 2018-11-20 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
CA2889504A1 (en) | 2012-11-07 | 2014-05-15 | Medtronic Minimed, Inc. | Dry insertion and one-point in vivo calibration of an optical analyte sensor |
US9265455B2 (en) | 2012-11-13 | 2016-02-23 | Medtronic Minimed, Inc. | Methods and systems for optimizing sensor function by the application of voltage |
US10194840B2 (en) | 2012-12-06 | 2019-02-05 | Medtronic Minimed, Inc. | Microarray electrodes useful with analyte sensors and methods for making and using them |
US10426383B2 (en) | 2013-01-22 | 2019-10-01 | Medtronic Minimed, Inc. | Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating |
US20140266636A1 (en) * | 2013-03-15 | 2014-09-18 | Cao Group, Inc. | Modular Professional Equipment Controlled by Mobile Device |
US9338819B2 (en) | 2013-05-29 | 2016-05-10 | Medtronic Minimed, Inc. | Variable data usage personal medical system and method |
US10194864B2 (en) | 2013-06-21 | 2019-02-05 | Medtronic Minimed, Inc. | Anchoring apparatus and method for attaching device on body |
US20140379360A1 (en) * | 2013-06-25 | 2014-12-25 | Lifescan, Inc. | Low glucose treatment for people with diabetes |
CN103340610A (en) * | 2013-06-26 | 2013-10-09 | 广州军区广州总医院 | Remote emergency medical system based on various wireless communication techniques |
US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
US8979799B1 (en) | 2013-10-14 | 2015-03-17 | Medtronic Minimed, Inc. | Electronic injector |
US9265881B2 (en) | 2013-10-14 | 2016-02-23 | Medtronic Minimed, Inc. | Therapeutic agent injection device |
US9375537B2 (en) | 2013-10-14 | 2016-06-28 | Medtronic Minimed, Inc. | Therapeutic agent injection device |
US8979808B1 (en) | 2013-10-14 | 2015-03-17 | Medtronic Minimed, Inc. | On-body injector and method of use |
US9226709B2 (en) | 2013-11-04 | 2016-01-05 | Medtronic Minimed, Inc. | ICE message system and method |
US9267875B2 (en) | 2013-11-21 | 2016-02-23 | Medtronic Minimed, Inc. | Accelerated life testing device and method |
US9750877B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Predicted time to assess and/or control a glycemic state |
US9849240B2 (en) | 2013-12-12 | 2017-12-26 | Medtronic Minimed, Inc. | Data modification for predictive operations and devices incorporating same |
US10105488B2 (en) | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
US9603561B2 (en) | 2013-12-16 | 2017-03-28 | Medtronic Minimed, Inc. | Methods and systems for improving the reliability of orthogonally redundant sensors |
US10321844B2 (en) | 2013-12-16 | 2019-06-18 | Medtronic Minimed, Inc. | In-vivo electrochemical impedance spectroscopy (EIS)-based calibration |
US9779226B2 (en) | 2013-12-18 | 2017-10-03 | Medtronic Minimed, Inc. | Fingerprint enhanced authentication for medical devices in wireless networks |
US9143941B2 (en) | 2013-12-18 | 2015-09-22 | Medtronic Minimed, Inc. | Secure communication by user selectable communication range |
US9694132B2 (en) | 2013-12-19 | 2017-07-04 | Medtronic Minimed, Inc. | Insertion device for insertion set |
US9861748B2 (en) | 2014-02-06 | 2018-01-09 | Medtronic Minimed, Inc. | User-configurable closed-loop notifications and infusion systems incorporating same |
US9388805B2 (en) | 2014-03-24 | 2016-07-12 | Medtronic Minimed, Inc. | Medication pump test device and method of use |
US9689830B2 (en) | 2014-04-03 | 2017-06-27 | Medtronic Minimed, Inc. | Sensor detection pads with integrated fuse |
US9707336B2 (en) | 2014-04-07 | 2017-07-18 | Medtronic Minimed, Inc. | Priming detection system and method of using the same |
US10232113B2 (en) | 2014-04-24 | 2019-03-19 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for regulating insulin on board |
US9681828B2 (en) | 2014-05-01 | 2017-06-20 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for forming such sensors |
US9901305B2 (en) | 2014-06-13 | 2018-02-27 | Medtronic Minimed, Inc. | Physiological sensor history backfill system and method |
US11185627B2 (en) | 2014-07-21 | 2021-11-30 | Medtronic Minimed, Inc. | Smart connection interface |
US9717845B2 (en) | 2014-08-19 | 2017-08-01 | Medtronic Minimed, Inc. | Geofencing for medical devices |
US20160051755A1 (en) | 2014-08-25 | 2016-02-25 | Medtronic Minimed, Inc. | Low cost fluid delivery device |
US9839753B2 (en) | 2014-09-26 | 2017-12-12 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US10279126B2 (en) | 2014-10-07 | 2019-05-07 | Medtronic Minimed, Inc. | Fluid conduit assembly with gas trapping filter in the fluid flow path |
US9592335B2 (en) | 2014-10-20 | 2017-03-14 | Medtronic Minimed, Inc. | Insulin pump data acquisition device |
US9841014B2 (en) | 2014-10-20 | 2017-12-12 | Medtronic Minimed, Inc. | Insulin pump data acquisition device and system |
US9731067B2 (en) | 2014-11-25 | 2017-08-15 | Medtronic Minimed, Inc. | Mechanical injection pump and method of use |
US9901675B2 (en) | 2014-11-25 | 2018-02-27 | Medtronic Minimed, Inc. | Infusion set insertion device and method of use |
US9636453B2 (en) | 2014-12-04 | 2017-05-02 | Medtronic Minimed, Inc. | Advance diagnosis of infusion device operating mode viability |
US9943645B2 (en) | 2014-12-04 | 2018-04-17 | Medtronic Minimed, Inc. | Methods for operating mode transitions and related infusion devices and systems |
US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
US9717848B2 (en) | 2015-01-22 | 2017-08-01 | Medtronic Minimed, Inc. | Data derived pre-bolus delivery |
US9872954B2 (en) | 2015-03-02 | 2018-01-23 | Medtronic Minimed, Inc. | Belt clip |
FR3033303B1 (en) * | 2015-03-03 | 2017-02-24 | Renault Sas | DEVICE AND METHOD FOR PREDICTING A LEVEL OF VIGILANCE IN A DRIVER OF A MOTOR VEHICLE. |
US10307528B2 (en) | 2015-03-09 | 2019-06-04 | Medtronic Minimed, Inc. | Extensible infusion devices and related methods |
US10449298B2 (en) | 2015-03-26 | 2019-10-22 | Medtronic Minimed, Inc. | Fluid injection devices and related methods |
US10130757B2 (en) | 2015-05-01 | 2018-11-20 | Medtronic Minimed, Inc. | Method and system for leakage detection in portable medical devices |
US9999721B2 (en) | 2015-05-26 | 2018-06-19 | Medtronic Minimed, Inc. | Error handling in infusion devices with distributed motor control and related operating methods |
US10478557B2 (en) | 2015-08-21 | 2019-11-19 | Medtronic Minimed, Inc. | Personalized parameter modeling methods and related devices and systems |
US10293108B2 (en) | 2015-08-21 | 2019-05-21 | Medtronic Minimed, Inc. | Infusion devices and related patient ratio adjustment methods |
US10463297B2 (en) | 2015-08-21 | 2019-11-05 | Medtronic Minimed, Inc. | Personalized event detection methods and related devices and systems |
US10201657B2 (en) | 2015-08-21 | 2019-02-12 | Medtronic Minimed, Inc. | Methods for providing sensor site rotation feedback and related infusion devices and systems |
US10117992B2 (en) | 2015-09-29 | 2018-11-06 | Medtronic Minimed, Inc. | Infusion devices and related rescue detection methods |
US9992818B2 (en) | 2015-10-06 | 2018-06-05 | Medtronic Minimed, Inc. | Protocol translation device |
US9757511B2 (en) | 2015-10-19 | 2017-09-12 | Medtronic Minimed, Inc. | Personal medical device and method of use with restricted mode challenge |
US11501867B2 (en) | 2015-10-19 | 2022-11-15 | Medtronic Minimed, Inc. | Medical devices and related event pattern presentation methods |
US11666702B2 (en) | 2015-10-19 | 2023-06-06 | Medtronic Minimed, Inc. | Medical devices and related event pattern treatment recommendation methods |
US10146911B2 (en) | 2015-10-23 | 2018-12-04 | Medtronic Minimed, Inc. | Medical devices and related methods and systems for data transfer |
US10037722B2 (en) | 2015-11-03 | 2018-07-31 | Medtronic Minimed, Inc. | Detecting breakage in a display element |
US10827959B2 (en) | 2015-11-11 | 2020-11-10 | Medtronic Minimed, Inc. | Sensor set |
DE102015224836A1 (en) | 2015-12-10 | 2017-06-14 | Volkswagen Aktiengesellschaft | Method for controlling a functional component of a motor vehicle by means of a medical implant of a user of the motor vehicle, computer program, control device for a motor vehicle and medical implant |
US9848805B2 (en) | 2015-12-18 | 2017-12-26 | Medtronic Minimed, Inc. | Biostable glucose permeable polymer |
US10327680B2 (en) | 2015-12-28 | 2019-06-25 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US20170181672A1 (en) | 2015-12-28 | 2017-06-29 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US20170184527A1 (en) | 2015-12-28 | 2017-06-29 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US10327686B2 (en) | 2015-12-28 | 2019-06-25 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US10349872B2 (en) | 2015-12-28 | 2019-07-16 | Medtronic Minimed, Inc. | Methods, systems, and devices for sensor fusion |
WO2017132690A1 (en) | 2016-01-28 | 2017-08-03 | Savor Labs, Inc. | Method and apparatus for tracking of food intake and other behaviors and providing relevant feedback |
US10790054B1 (en) | 2016-12-07 | 2020-09-29 | Medtronic Minimed, Inc. | Method and apparatus for tracking of food intake and other behaviors and providing relevant feedback |
US10765348B2 (en) | 2016-04-08 | 2020-09-08 | Medtronic Minimed, Inc. | Sensor and transmitter product |
US10631787B2 (en) | 2016-04-08 | 2020-04-28 | Medtronic Minimed, Inc. | Sensor and transmitter product |
US10765369B2 (en) | 2016-04-08 | 2020-09-08 | Medtronic Minimed, Inc. | Analyte sensor |
US10589038B2 (en) | 2016-04-27 | 2020-03-17 | Medtronic Minimed, Inc. | Set connector systems for venting a fluid reservoir |
US10324058B2 (en) | 2016-04-28 | 2019-06-18 | Medtronic Minimed, Inc. | In-situ chemistry stack for continuous glucose sensors |
US9970893B2 (en) | 2016-04-28 | 2018-05-15 | Medtronic Minimed, Inc. | Methods, systems, and devices for electrode capacitance calculation and application |
US10426389B2 (en) | 2016-04-28 | 2019-10-01 | Medtronic Minimed, Inc. | Methods, systems, and devices for electrode capacitance calculation and application |
US9968737B2 (en) | 2016-05-26 | 2018-05-15 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
US10086134B2 (en) | 2016-05-26 | 2018-10-02 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
US10086133B2 (en) | 2016-05-26 | 2018-10-02 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
US11134872B2 (en) | 2016-06-06 | 2021-10-05 | Medtronic Minimed, Inc. | Thermally stable glucose limiting membrane for glucose sensors |
US11179078B2 (en) | 2016-06-06 | 2021-11-23 | Medtronic Minimed, Inc. | Polycarbonate urea/urethane polymers for use with analyte sensors |
US10485924B2 (en) | 2016-09-06 | 2019-11-26 | Medtronic Minimed, Inc. | Pump clip for a fluid infusion device |
US10861591B2 (en) | 2016-12-21 | 2020-12-08 | Medtronic Minimed, Inc. | Infusion systems and methods for pattern-based therapy adjustments |
US10709834B2 (en) | 2016-12-21 | 2020-07-14 | Medtronic Minimed, Inc. | Medication fluid infusion set component with integrated physiological analyte sensor, and corresponding fluid infusion device |
US10272201B2 (en) | 2016-12-22 | 2019-04-30 | Medtronic Minimed, Inc. | Insertion site monitoring methods and related infusion devices and systems |
US11197949B2 (en) | 2017-01-19 | 2021-12-14 | Medtronic Minimed, Inc. | Medication infusion components and systems |
US10821225B2 (en) | 2017-01-20 | 2020-11-03 | Medtronic Minimed, Inc. | Cannulas for drug delivery devices |
US10552580B2 (en) | 2017-02-07 | 2020-02-04 | Medtronic Minimed, Inc. | Infusion system consumables and related calibration methods |
KR102568511B1 (en) * | 2017-02-10 | 2023-08-31 | 코닌클리케 필립스 엔.브이. | Warning system of onset of hypoglycemic event during driving of vehicle |
US10646649B2 (en) | 2017-02-21 | 2020-05-12 | Medtronic Minimed, Inc. | Infusion devices and fluid identification apparatuses and methods |
US11986288B2 (en) | 2017-03-06 | 2024-05-21 | Medtronic Minimed, Inc. | Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes |
US11134868B2 (en) | 2017-03-17 | 2021-10-05 | Medtronic Minimed, Inc. | Metal pillar device structures and methods for making and using them in electrochemical and/or electrocatalytic applications |
US11350886B2 (en) | 2017-03-24 | 2022-06-07 | Medtronic Minimed, Inc. | Context-sensitive infusion devices, systems and methods |
US20180328877A1 (en) | 2017-05-11 | 2018-11-15 | Medtronic Minimed, Inc. | Analyte sensors and methods for fabricating analyte sensors |
US11493348B2 (en) | 2017-06-23 | 2022-11-08 | Direct Current Capital LLC | Methods for executing autonomous rideshare requests |
US10856784B2 (en) | 2017-06-30 | 2020-12-08 | Medtronic Minimed, Inc. | Sensor initialization methods for faster body sensor response |
US10596295B2 (en) | 2017-08-28 | 2020-03-24 | Medtronic Minimed, Inc. | Adhesive patch arrangement for a physiological characteristic sensor, and related sensor assembly |
US11412960B2 (en) | 2017-08-28 | 2022-08-16 | Medtronic Minimed, Inc. | Pedestal for sensor assembly packaging and sensor introducer removal |
US11311217B2 (en) | 2017-09-13 | 2022-04-26 | Medtronic Minimed, Inc. | Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output |
US10874300B2 (en) | 2017-09-26 | 2020-12-29 | Medtronic Minimed, Inc. | Waferscale physiological characteristic sensor package with integrated wireless transmitter |
US10524730B2 (en) | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Medical devices with microneedle arrays and methods for operating such medical devices |
US10525244B2 (en) | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Microneedle arrays and methods for fabricating microneedle arrays |
US11676734B2 (en) | 2017-11-15 | 2023-06-13 | Medtronic Minimed, Inc. | Patient therapy management system that leverages aggregated patient population data |
US11213230B2 (en) | 2017-12-13 | 2022-01-04 | Medtronic Minimed, Inc. | Optional sensor calibration in continuous glucose monitoring |
US11471082B2 (en) | 2017-12-13 | 2022-10-18 | Medtronic Minimed, Inc. | Complex redundancy in continuous glucose monitoring |
US11106927B2 (en) * | 2017-12-27 | 2021-08-31 | Direct Current Capital LLC | Method for monitoring an interior state of an autonomous vehicle |
US11439352B2 (en) | 2018-01-17 | 2022-09-13 | Medtronic Minimed, Inc. | Medical device with adhesive patch longevity |
US12042284B2 (en) | 2018-01-23 | 2024-07-23 | Medtronic Minimed, Inc. | Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses |
US11186859B2 (en) | 2018-02-07 | 2021-11-30 | Medtronic Minimed, Inc. | Multilayer electrochemical analyte sensors and methods for making and using them |
US11220735B2 (en) | 2018-02-08 | 2022-01-11 | Medtronic Minimed, Inc. | Methods for controlling physical vapor deposition metal film adhesion to substrates and surfaces |
US11583213B2 (en) | 2018-02-08 | 2023-02-21 | Medtronic Minimed, Inc. | Glucose sensor electrode design |
US10853629B2 (en) | 2018-02-20 | 2020-12-01 | Direct Current Capital LLC | Method for identifying a user entering an autonomous vehicle |
US11672446B2 (en) | 2018-03-23 | 2023-06-13 | Medtronic Minimed, Inc. | Insulin delivery recommendations based on nutritional information |
US11147919B2 (en) | 2018-04-23 | 2021-10-19 | Medtronic Minimed, Inc. | Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system |
US11158413B2 (en) | 2018-04-23 | 2021-10-26 | Medtronic Minimed, Inc. | Personalized closed loop medication delivery system that utilizes a digital twin of the patient |
US10861603B2 (en) | 2018-05-07 | 2020-12-08 | Medtronic Minimed, Inc. | Proactive image-based infusion device delivery adjustments |
US11761077B2 (en) | 2018-08-01 | 2023-09-19 | Medtronic Minimed, Inc. | Sputtering techniques for biosensors |
US11122697B2 (en) | 2018-08-07 | 2021-09-14 | Medtronic Minimed, Inc. | Method of fabricating an electronic medical device, including overmolding an assembly with thermoplastic material |
US11021731B2 (en) | 2018-08-23 | 2021-06-01 | Medtronic Minimed, Inc. | Analyte sensing layers, analyte sensors and methods for fabricating the same |
US10828419B2 (en) | 2018-09-04 | 2020-11-10 | Medtronic Minimed, Inc. | Infusion set with pivoting metal cannula and strain relief |
US11547799B2 (en) | 2018-09-20 | 2023-01-10 | Medtronic Minimed, Inc. | Patient day planning systems and methods |
DE102018216128B4 (en) * | 2018-09-21 | 2022-12-29 | Audi Ag | Method for operating a motor vehicle system, monitoring device, and motor vehicle |
US11097052B2 (en) | 2018-09-28 | 2021-08-24 | Medtronic Minimed, Inc. | Insulin infusion device with configurable target blood glucose value for automatic basal insulin delivery operation |
US10980942B2 (en) | 2018-09-28 | 2021-04-20 | Medtronic Minimed, Inc. | Infusion devices and related meal bolus adjustment methods |
US11071821B2 (en) | 2018-09-28 | 2021-07-27 | Medtronic Minimed, Inc. | Insulin infusion device with efficient confirmation routine for blood glucose measurements |
US10894126B2 (en) | 2018-09-28 | 2021-01-19 | Medtronic Minimed, Inc. | Fluid infusion system that automatically determines and delivers a correction bolus |
US20200116748A1 (en) | 2018-10-11 | 2020-04-16 | Medtronic Minimed, Inc. | Systems and methods for measurement of fluid delivery |
US10946140B2 (en) | 2018-10-11 | 2021-03-16 | Medtronic Minimed, Inc. | Systems and methods for measurement of fluid delivery |
US20200135320A1 (en) | 2018-10-31 | 2020-04-30 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a medication dispensing system based on historical events |
US11363986B2 (en) | 2018-10-31 | 2022-06-21 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a medication dispensing system |
US20200289373A1 (en) | 2018-10-31 | 2020-09-17 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a physiological characteristic sensor device |
US11367517B2 (en) | 2018-10-31 | 2022-06-21 | Medtronic Minimed, Inc. | Gesture-based detection of a physical behavior event based on gesture sensor data and supplemental information from at least one external source |
US11382541B2 (en) | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
DE102018128891A1 (en) * | 2018-11-16 | 2020-05-20 | Bayerische Motoren Werke Aktiengesellschaft | Method, device and system for controlling at least one vehicle function |
US11540750B2 (en) | 2018-12-19 | 2023-01-03 | Medtronic Minimed, Inc | Systems and methods for physiological characteristic monitoring |
US11439752B2 (en) | 2019-02-01 | 2022-09-13 | Medtronic Minimed, Inc. | Methods and devices for occlusion detection using actuator sensors |
US11389587B2 (en) | 2019-02-06 | 2022-07-19 | Medtronic Minimed, Inc. | Patient monitoring systems and related presentation methods |
US11191899B2 (en) | 2019-02-12 | 2021-12-07 | Medtronic Minimed, Inc. | Infusion systems and related personalized bolusing methods |
US12082910B2 (en) | 2019-02-12 | 2024-09-10 | Medtronic Minimed, Inc. | Miniaturized noninvasive glucose sensor and continuous glucose monitoring system |
US11311215B2 (en) | 2019-04-04 | 2022-04-26 | Medtronic Minimed, Inc. | Measurement of device materials using non-Faradaic electrochemical impedance spectroscopy |
US11986629B2 (en) | 2019-06-11 | 2024-05-21 | Medtronic Minimed, Inc. | Personalized closed loop optimization systems and methods |
US11317867B2 (en) | 2019-04-23 | 2022-05-03 | Medtronic Minimed, Inc. | Flexible physiological characteristic sensor assembly |
US11224361B2 (en) | 2019-04-23 | 2022-01-18 | Medtronic Minimed, Inc. | Flexible physiological characteristic sensor assembly |
US10939488B2 (en) | 2019-05-20 | 2021-03-02 | Medtronic Minimed, Inc. | Method and system for controlling communication between devices of a wireless body area network for an medical device system |
US11642454B2 (en) | 2019-06-06 | 2023-05-09 | Medtronic Minimed, Inc. | Fluid infusion systems |
US11448611B2 (en) | 2019-07-03 | 2022-09-20 | Medtronic Minimed, Inc. | Structurally reinforced sensor and method for manufacturing the same |
US11617828B2 (en) | 2019-07-17 | 2023-04-04 | Medtronic Minimed, Inc. | Reservoir connection interface with detectable signature |
US11718865B2 (en) | 2019-07-26 | 2023-08-08 | Medtronic Minimed, Inc. | Methods to improve oxygen delivery to implantable sensors |
US11523757B2 (en) | 2019-08-01 | 2022-12-13 | Medtronic Minimed, Inc. | Micro-pillar working electrodes design to reduce backflow of hydrogen peroxide in glucose sensor |
US11883208B2 (en) | 2019-08-06 | 2024-01-30 | Medtronic Minimed, Inc. | Machine learning-based system for estimating glucose values based on blood glucose measurements and contextual activity data |
US20220039755A1 (en) | 2020-08-06 | 2022-02-10 | Medtronic Minimed, Inc. | Machine learning-based system for estimating glucose values |
US11617522B2 (en) | 2019-08-06 | 2023-04-04 | Medtronic Minimed, Inc. | Sensor inserter with disposal lockout state |
US11724045B2 (en) | 2019-08-21 | 2023-08-15 | Medtronic Minimed, Inc. | Connection of a stopper and piston in a fluid delivery device |
US20210060244A1 (en) | 2019-08-28 | 2021-03-04 | Medtronic Minimed, Inc. | Method and system for verifying whether a non-medical client device is operating correctly with a medical device controlled by the non-medical client device and causing a notification to be generated |
US11992656B2 (en) | 2019-08-29 | 2024-05-28 | Medtronic Minimed, Inc. | Controlling medical infusion device operation and features based on detected patient sleeping status |
US11654235B2 (en) | 2019-09-12 | 2023-05-23 | Medtronic Minimed, Inc. | Sensor calibration using fabrication measurements |
US11565044B2 (en) | 2019-09-12 | 2023-01-31 | Medtronic Minimed, Inc. | Manufacturing controls for sensor calibration using fabrication measurements |
US11213623B2 (en) | 2019-09-20 | 2022-01-04 | Medtronic Minimed, Inc. | Infusion systems and related personalized bolusing methods |
US11241537B2 (en) | 2019-09-20 | 2022-02-08 | Medtronic Minimed, Inc. | Contextual personalized closed-loop adjustment methods and systems |
US11511099B2 (en) | 2019-10-08 | 2022-11-29 | Medtronic Minimed, Inc. | Apparatus for detecting mating of a cap with a fluid delivery device and method |
US11638545B2 (en) | 2019-10-16 | 2023-05-02 | Medtronic Minimed, Inc. | Reducing sensor foreign body response via high surface area metal structures |
US11496083B2 (en) | 2019-11-15 | 2022-11-08 | Medtronic Minimed, Inc. | Devices and methods for controlling electromechanical actuators |
US11944784B2 (en) | 2019-11-18 | 2024-04-02 | Medtronic Minimed, Inc. | Combined analyte sensor and infusion set |
US11559624B2 (en) | 2019-11-21 | 2023-01-24 | Medtronic Minimed, Inc. | Systems for wearable infusion port and associated pump |
US11324881B2 (en) | 2019-11-21 | 2022-05-10 | Medtronic Minimed, Inc. | Systems for wearable infusion port and associated pump |
US11670425B2 (en) | 2019-12-09 | 2023-06-06 | Medtronic Minimed, Inc. | Translation modeling methods and systems for simulating sensor measurements |
US11488700B2 (en) | 2019-12-13 | 2022-11-01 | Medtronic Minimed, Inc. | Medical device configuration procedure guidance responsive to detected gestures |
US11786655B2 (en) | 2019-12-13 | 2023-10-17 | Medtronic Minimed, Inc. | Context-sensitive predictive operation of a medication delivery system in response to gesture-indicated activity changes |
US11938301B2 (en) | 2019-12-13 | 2024-03-26 | Medtronic Minimed, Inc. | Controlling medication delivery system operation and features based on automatically detected muscular movements |
US20210183491A1 (en) | 2019-12-13 | 2021-06-17 | Medtronic Minimed, Inc. | Method and system for training a mathematical model based on labeled events and/or labeled event combinations |
US11690573B2 (en) | 2019-12-18 | 2023-07-04 | Medtronic Minimed, Inc. | Systems for skin patch gravity resistance |
US11375955B2 (en) | 2019-12-18 | 2022-07-05 | Medtronic Minimed, Inc. | Systems for skin patch gravity resistance |
US11821022B2 (en) | 2019-12-23 | 2023-11-21 | Medtronic Minimed, Inc. | Ethylene oxide absorption layer for analyte sensing and method |
US11244753B2 (en) | 2020-01-30 | 2022-02-08 | Medtronic Minimed, Inc. | Activity monitoring systems and methods |
US11957488B2 (en) | 2020-02-07 | 2024-04-16 | Medtronic Minimed, Inc. | Systems for medical device breathability |
US11833327B2 (en) | 2020-03-06 | 2023-12-05 | Medtronic Minimed, Inc. | Analyte sensor configuration and calibration based on data collected from a previously used analyte sensor |
USD958167S1 (en) | 2020-03-23 | 2022-07-19 | Companion Medical, Inc. | Display screen with graphical user interface |
USD958817S1 (en) | 2020-03-31 | 2022-07-26 | Medtronic Minimed, Inc. | Display screen with graphical user interface |
US11596359B2 (en) | 2020-04-09 | 2023-03-07 | Medtronic Minimed, Inc. | Methods and systems for mitigating sensor error propagation |
US11690955B2 (en) | 2020-04-23 | 2023-07-04 | Medtronic Minimed, Inc. | Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system |
US11583631B2 (en) | 2020-04-23 | 2023-02-21 | Medtronic Minimed, Inc. | Intuitive user interface features and related functionality for a therapy delivery system |
DE102020112310A1 (en) | 2020-05-06 | 2021-11-11 | Audi Aktiengesellschaft | Motor vehicle |
US11272884B2 (en) | 2020-06-04 | 2022-03-15 | Medtronic Minimed, Inc. | Liner for adhesive skin patch |
US12064236B2 (en) | 2020-06-11 | 2024-08-20 | Medtronic Minimed, Inc. | Methods, systems, and devices for improved sensors for continuous glucose monitoring |
US11650248B2 (en) | 2020-07-28 | 2023-05-16 | Medtronic Minimed, Inc. | Electrical current measurement system |
US11960311B2 (en) | 2020-07-28 | 2024-04-16 | Medtronic Minimed, Inc. | Linear voltage regulator with isolated supply current |
US12082924B2 (en) | 2020-07-31 | 2024-09-10 | Medtronic Minimed, Inc. | Sensor identification and integrity check design |
US11445807B2 (en) | 2020-07-31 | 2022-09-20 | Medtronic Minimed, Inc. | Pump clip with tube clamp for a fluid infusion device |
US11839743B2 (en) | 2020-10-07 | 2023-12-12 | Medtronic Minimed, Inc. | Graphic user interface for automated infusate delivery |
US11737783B2 (en) | 2020-10-16 | 2023-08-29 | Medtronic Minimed, Inc. | Disposable medical device introduction system |
US11844930B2 (en) | 2020-10-29 | 2023-12-19 | Medtronic Minimed, Inc. | User-mountable electronic device with accelerometer-based activation feature |
US11806503B2 (en) | 2020-10-29 | 2023-11-07 | Medtronic Minimed, Inc. | Removable wearable device and related attachment methods |
US11534086B2 (en) | 2020-10-30 | 2022-12-27 | Medtronic Minimed, Inc. | Low-profile wearable medical device |
US11951281B2 (en) | 2020-11-11 | 2024-04-09 | Medtronic Minimed, Inc. | Fluid conduit insertion devices |
DE102021100985A1 (en) * | 2021-01-19 | 2022-07-21 | Audi Aktiengesellschaft | METHOD, COMPUTER PROGRAM AND DEVICE FOR CONTROLLING A PLAYBACK OF CONFIDENTIAL INFORMATION IN A MEANS OF TRANSPORTATION |
US11998330B2 (en) | 2021-01-29 | 2024-06-04 | Medtronic Minimed, Inc. | Interference rejection membranes useful with analyte sensors |
WO2022169753A1 (en) | 2021-02-02 | 2022-08-11 | Medtronic Minimed, Inc. | Dynamic adjustments of physiological data |
US11904146B2 (en) | 2021-06-08 | 2024-02-20 | Medtronic Minimed, Inc. | Medicine injection devices, systems, and methods for medicine administration and tracking |
US11792714B2 (en) | 2021-06-16 | 2023-10-17 | Medtronic Minimed, Inc. | Medicine administration in dynamic networks |
US11817285B2 (en) | 2021-09-02 | 2023-11-14 | Medtronic Minimed, Inc. | Ingress-tolerant input devices comprising sliders |
US11587742B1 (en) | 2021-09-02 | 2023-02-21 | Medtronic Minimed, Inc. | Ingress-tolerant input devices |
US11896447B2 (en) | 2022-03-14 | 2024-02-13 | Medtronic Minimed, Inc. | Safeguards against separation from portable medicine delivery devices |
US12011293B2 (en) | 2022-04-26 | 2024-06-18 | Medtronic Minimed, Inc. | Energy management based on a closed switch configuration |
US11997806B2 (en) * | 2022-04-26 | 2024-05-28 | Medtronic Minimed, Inc. | Energy management based on an open switch configuration |
US11904877B1 (en) * | 2022-09-23 | 2024-02-20 | Arnold Chase | Vehicle medical device interface system |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664127A (en) * | 1984-08-28 | 1987-05-12 | Aisin Seiki Kabushiki Kaisha | Vehicle-loaded heartbeat meter |
US6104296A (en) * | 1998-02-18 | 2000-08-15 | Pioneer Electronic Corporation | Biological information detection apparatus |
US20040186365A1 (en) * | 2002-12-31 | 2004-09-23 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US6809653B1 (en) * | 1998-10-08 | 2004-10-26 | Medtronic Minimed, Inc. | Telemetered characteristic monitor system and method of using the same |
US20040240712A1 (en) * | 2003-04-04 | 2004-12-02 | Lumidigm, Inc. | Multispectral biometric sensor |
US20050003470A1 (en) * | 2003-06-10 | 2005-01-06 | Therasense, Inc. | Glucose measuring device for use in personal area network |
US20060193278A1 (en) * | 1997-10-15 | 2006-08-31 | Wolfgang Theimer | Mobile telephone for Internet applications |
US20060258929A1 (en) * | 2005-03-10 | 2006-11-16 | Goode Paul V Jr | System and methods for processing analyte sensor data for sensor calibration |
US20060267781A1 (en) * | 2005-05-24 | 2006-11-30 | Coulter Jeffery R | Process and method for safer vehicle navigation through facial gesture recognition and operator condition monitoring |
US20060281980A1 (en) * | 2003-10-13 | 2006-12-14 | Novo Nordisk A/S | Apparatus and method for determining a physiological condition |
US20070112261A1 (en) * | 2005-08-24 | 2007-05-17 | Medtronic Minimed, Inc. | Automobile Glucose Sensor Monitoring System and Method for Using the Same |
US20070241915A1 (en) * | 2003-12-22 | 2007-10-18 | International Business Machines Corporation | Medical applications in telematics |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19742261C2 (en) * | 1997-09-25 | 2003-04-17 | Draeger Safety Ag & Co Kgaa | Device for blocking the operation of a vehicle or a machine |
GB2415036A (en) | 2004-06-09 | 2005-12-14 | Johnson William N H | Security device |
US20060020216A1 (en) | 2004-07-20 | 2006-01-26 | Sharp Kabushiki Kaisha | Medical information detection apparatus and health management system using the medical information detection apparatus |
-
2009
- 2009-04-15 US US12/423,964 patent/US8207859B2/en active Active
- 2009-04-15 US US12/424,010 patent/US20090270705A1/en not_active Abandoned
- 2009-04-15 US US12/423,976 patent/US8207860B2/en active Active
- 2009-04-16 WO PCT/US2009/040772 patent/WO2009134622A1/en active Application Filing
- 2009-04-16 EP EP09739424.1A patent/EP2278910B8/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664127A (en) * | 1984-08-28 | 1987-05-12 | Aisin Seiki Kabushiki Kaisha | Vehicle-loaded heartbeat meter |
US20060193278A1 (en) * | 1997-10-15 | 2006-08-31 | Wolfgang Theimer | Mobile telephone for Internet applications |
US6104296A (en) * | 1998-02-18 | 2000-08-15 | Pioneer Electronic Corporation | Biological information detection apparatus |
US6809653B1 (en) * | 1998-10-08 | 2004-10-26 | Medtronic Minimed, Inc. | Telemetered characteristic monitor system and method of using the same |
US20040186365A1 (en) * | 2002-12-31 | 2004-09-23 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US20040240712A1 (en) * | 2003-04-04 | 2004-12-02 | Lumidigm, Inc. | Multispectral biometric sensor |
US20050003470A1 (en) * | 2003-06-10 | 2005-01-06 | Therasense, Inc. | Glucose measuring device for use in personal area network |
US20060281980A1 (en) * | 2003-10-13 | 2006-12-14 | Novo Nordisk A/S | Apparatus and method for determining a physiological condition |
US20070241915A1 (en) * | 2003-12-22 | 2007-10-18 | International Business Machines Corporation | Medical applications in telematics |
US20060258929A1 (en) * | 2005-03-10 | 2006-11-16 | Goode Paul V Jr | System and methods for processing analyte sensor data for sensor calibration |
US20060267781A1 (en) * | 2005-05-24 | 2006-11-30 | Coulter Jeffery R | Process and method for safer vehicle navigation through facial gesture recognition and operator condition monitoring |
US20070112261A1 (en) * | 2005-08-24 | 2007-05-17 | Medtronic Minimed, Inc. | Automobile Glucose Sensor Monitoring System and Method for Using the Same |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11291763B2 (en) | 2007-03-13 | 2022-04-05 | Tandem Diabetes Care, Inc. | Basal rate testing using frequent blood glucose input |
US10357607B2 (en) | 2007-05-24 | 2019-07-23 | Tandem Diabetes Care, Inc. | Correction factor testing using frequent blood glucose input |
US9474856B2 (en) | 2007-05-24 | 2016-10-25 | Tandem Diabetes Care, Inc. | Expert system for infusion pump therapy |
US11257580B2 (en) | 2007-05-24 | 2022-02-22 | Tandem Diabetes Care, Inc. | Expert system for insulin pump therapy |
US11848089B2 (en) | 2007-05-24 | 2023-12-19 | Tandem Diabetes Care, Inc. | Expert system for insulin pump therapy |
US10943687B2 (en) | 2007-05-24 | 2021-03-09 | Tandem Diabetes Care, Inc. | Expert system for insulin pump therapy |
US11576594B2 (en) | 2007-05-30 | 2023-02-14 | Tandem Diabetes Care, Inc. | Insulin pump based expert system |
US11298053B2 (en) | 2007-05-30 | 2022-04-12 | Tandem Diabetes Care, Inc. | Insulin pump based expert system |
US9833177B2 (en) | 2007-05-30 | 2017-12-05 | Tandem Diabetes Care, Inc. | Insulin pump based expert system |
US11986292B2 (en) | 2007-05-30 | 2024-05-21 | Tandem Diabetes Care, Inc. | Insulin pump based expert system |
US11302433B2 (en) | 2008-01-07 | 2022-04-12 | Tandem Diabetes Care, Inc. | Diabetes therapy coaching |
US8718949B2 (en) | 2008-01-07 | 2014-05-06 | Tandem Diabetes Care, Inc. | Insulin pump with blood glucose modules |
US10052049B2 (en) | 2008-01-07 | 2018-08-21 | Tandem Diabetes Care, Inc. | Infusion pump with blood glucose alert delay |
US8758323B2 (en) | 2009-07-30 | 2014-06-24 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US12042627B2 (en) | 2009-07-30 | 2024-07-23 | Tandem Diabetes Care, Inc. | Infusion pump systems and methods |
US9211377B2 (en) | 2009-07-30 | 2015-12-15 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US11285263B2 (en) | 2009-07-30 | 2022-03-29 | Tandem Diabetes Care, Inc. | Infusion pump systems and methods |
US8926561B2 (en) | 2009-07-30 | 2015-01-06 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US11135362B2 (en) | 2009-07-30 | 2021-10-05 | Tandem Diabetes Care, Inc. | Infusion pump systems and methods |
US8298184B2 (en) | 2009-07-30 | 2012-10-30 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US8287495B2 (en) | 2009-07-30 | 2012-10-16 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US10016559B2 (en) | 2009-12-04 | 2018-07-10 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
US11090432B2 (en) | 2009-12-04 | 2021-08-17 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
US20110178382A1 (en) * | 2010-01-19 | 2011-07-21 | Topp Claire H | Blood glucose ignition interlock |
US9973883B2 (en) * | 2010-03-15 | 2018-05-15 | Welch Allyn, Inc. | Personal area network pairing |
US9662016B2 (en) * | 2010-03-15 | 2017-05-30 | Welch Allyn, Inc. | Personal area network pairing |
US20170223490A1 (en) * | 2010-03-15 | 2017-08-03 | Welch Allyn, Inc. | Personal Area Network Pairing |
US20170035296A1 (en) * | 2010-03-15 | 2017-02-09 | Welch Allyn, Inc. | Personal Area Network Pairing |
US9164801B2 (en) | 2010-06-08 | 2015-10-20 | International Business Machines Corporation | Probabilistic optimization of resource discovery, reservation and assignment |
US9646271B2 (en) | 2010-08-06 | 2017-05-09 | International Business Machines Corporation | Generating candidate inclusion/exclusion cohorts for a multiply constrained group |
US20120059227A1 (en) * | 2010-09-03 | 2012-03-08 | International Business Machines Corporation | Directing a user to a medical resource |
US8968197B2 (en) * | 2010-09-03 | 2015-03-03 | International Business Machines Corporation | Directing a user to a medical resource |
US9292577B2 (en) | 2010-09-17 | 2016-03-22 | International Business Machines Corporation | User accessibility to data analytics |
US20140179256A1 (en) * | 2010-11-08 | 2014-06-26 | Ford Global Technologies, Llc | Vehicle System Reaction to Medical Conditions |
US9208289B2 (en) * | 2010-11-08 | 2015-12-08 | Ford Global Technologies, Llc | Vehicle system reaction to medical conditions |
US20170068438A1 (en) * | 2011-11-16 | 2017-03-09 | Autoconnect Holdings Llc | Gesture recognition for on-board display |
US9977593B2 (en) * | 2011-11-16 | 2018-05-22 | Autoconnect Holdings Llc | Gesture recognition for on-board display |
US10258736B2 (en) | 2012-05-17 | 2019-04-16 | Tandem Diabetes Care, Inc. | Systems including vial adapter for fluid transfer |
US11676694B2 (en) | 2012-06-07 | 2023-06-13 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
US11213204B2 (en) | 2012-12-31 | 2022-01-04 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US11744463B2 (en) | 2012-12-31 | 2023-09-05 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US11160452B2 (en) | 2012-12-31 | 2021-11-02 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10860687B2 (en) | 2012-12-31 | 2020-12-08 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10993617B2 (en) | 2012-12-31 | 2021-05-04 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10856736B2 (en) | 2012-12-31 | 2020-12-08 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US10869599B2 (en) | 2012-12-31 | 2020-12-22 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US11109757B2 (en) | 2012-12-31 | 2021-09-07 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US11382508B2 (en) | 2012-12-31 | 2022-07-12 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US11850020B2 (en) | 2012-12-31 | 2023-12-26 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US9962486B2 (en) | 2013-03-14 | 2018-05-08 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10864322B2 (en) | 2013-09-06 | 2020-12-15 | Tandem Diabetes Care, Inc. | System and method for mitigating risk in automated medicament dosing |
US9486169B1 (en) | 2014-04-18 | 2016-11-08 | Invoy Technologies, Llc | Ketone measurement system and related method with accuracy and reporting enhancement features |
US11779271B2 (en) | 2014-07-23 | 2023-10-10 | Invoy Holdings Inc. | Breath analysis system with measurement tagging interface |
US9351684B1 (en) | 2014-07-23 | 2016-05-31 | Invoy Technologies, Inc. | Ketone measurement system with user interface for efficient categorization of measurements |
US9314204B1 (en) | 2014-07-23 | 2016-04-19 | Invoy Technologies, Llc | Ketone measurement system capable of validating measurements against behavioral rules |
US9341632B1 (en) | 2014-07-23 | 2016-05-17 | Invoy Technologies, Inc. | Ketone measurement system capable of detecting correlations between measurements and user behaviors |
US11832963B2 (en) | 2014-07-23 | 2023-12-05 | Invoy Holdings Inc. | Breath analysis system |
US11253194B2 (en) | 2014-07-23 | 2022-02-22 | Invoy Holdings Inc. | Analyte measurement analysis using baseline levels |
US10433786B2 (en) | 2014-07-23 | 2019-10-08 | Invoy Holdings, Llc | Breath ketone measurements system capable of detecting ketone measurement patterns associated with program non-compliance events |
US10278640B2 (en) | 2014-07-23 | 2019-05-07 | Invoy Holdings, Llc | Breath ketone measurement system with analysis unit that communicates with mobile application |
US9504422B2 (en) | 2014-07-23 | 2016-11-29 | Invoy Technologies, Llc | Breath acetone measurement system with portable base unit that communicates with mobile application |
US20160270724A1 (en) * | 2014-07-23 | 2016-09-22 | Invoy Technologies, Llc | Ketone measurement system capable of detecting and notifying a user of proper insertion of detachable components |
US9299238B1 (en) * | 2014-07-23 | 2016-03-29 | Invoy Technologies, Llc | Ketone measurement system capable of detecting and notifying a user of proper insertion of detachable components |
US9669160B2 (en) | 2014-07-30 | 2017-06-06 | Tandem Diabetes Care, Inc. | Temporary suspension for closed-loop medicament therapy |
US20160138492A1 (en) * | 2014-11-13 | 2016-05-19 | Infineon Technologies Ag | Reduced Power Consumption with Sensors Transmitting Data Using Current Modulation |
US10012154B2 (en) * | 2014-11-13 | 2018-07-03 | Infineon Technologies Ag | Reduced power consumption with sensors transmitting data using current modulation |
US9599986B1 (en) * | 2015-12-22 | 2017-03-21 | International Business Machines Corporation | Emergency automated vehicle control system to monitor emergency medical events through body area networks |
US20170181630A1 (en) * | 2015-12-28 | 2017-06-29 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
US11399721B2 (en) | 2015-12-28 | 2022-08-02 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
US10932672B2 (en) * | 2015-12-28 | 2021-03-02 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
US11638781B2 (en) | 2015-12-29 | 2023-05-02 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
US10583842B1 (en) * | 2018-08-31 | 2020-03-10 | Toyota Motor Engineering & Manufacturing North America, Inc. | Driver state detection based on glycemic condition |
US11984223B2 (en) | 2019-02-19 | 2024-05-14 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US10888655B2 (en) | 2019-02-19 | 2021-01-12 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US11464901B2 (en) | 2019-02-19 | 2022-10-11 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US11305057B2 (en) | 2019-03-26 | 2022-04-19 | Tandem Diabetes Care, Inc. | Method and system of operating an infusion pump with a remote control device |
US10861308B1 (en) * | 2019-05-29 | 2020-12-08 | Siemens Industry, Inc. | System and method to improve emergency response time |
WO2022235666A1 (en) * | 2021-05-03 | 2022-11-10 | Mindset Medical, Inc. | Server, systems and methods for automating safety actions using monitored parameters |
GB2617105A (en) * | 2022-03-29 | 2023-10-04 | Jaguar Land Rover Ltd | In-vehicle blood glucose level monitoring |
Also Published As
Publication number | Publication date |
---|---|
WO2009134622A1 (en) | 2009-11-05 |
US8207860B2 (en) | 2012-06-26 |
EP2278910B1 (en) | 2019-01-02 |
EP2278910B8 (en) | 2019-05-08 |
US8207859B2 (en) | 2012-06-26 |
US20090267775A1 (en) | 2009-10-29 |
US20090267774A1 (en) | 2009-10-29 |
EP2278910A1 (en) | 2011-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8207860B2 (en) | Automobile physiological monitoring system and method for using the same | |
US20070112261A1 (en) | Automobile Glucose Sensor Monitoring System and Method for Using the Same | |
US11147915B2 (en) | Diabetes management system | |
US10939859B2 (en) | Mitigating single point failure of devices in an analyte monitoring system and methods thereof | |
EP2502172B1 (en) | Hypoglycemic treatment systems | |
US20080166992A1 (en) | Mobile emergency alert system | |
US9122775B2 (en) | Medical data acquisition and provision | |
JP6476124B2 (en) | Apparatus and method for monitoring physical function and / or physical characteristics | |
US8545483B2 (en) | Physiological sensors with telemonitor and notification systems | |
KR102303023B1 (en) | Taxi nomitoring system using smart band, gateway module and integrated control device connected with taxi service using smart band | |
US9226709B2 (en) | ICE message system and method | |
US10276038B2 (en) | Remote notification system for medical devices | |
JP2005168908A (en) | Driver's health monitoring system using car | |
US20240136059A1 (en) | Vehicle medical device interface system | |
US11904877B1 (en) | Vehicle medical device interface system | |
CN118419034A (en) | Driving assistance method, program product, and driving assistance system for vehicle | |
GB2617105A (en) | In-vehicle blood glucose level monitoring | |
CN116439478A (en) | Safety driving monitoring bracelet based on skin sweat and monitoring method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ENEGREN, BRADLEY J.;PATEL, HIMANSHU;MADZAR, BOGDAN;AND OTHERS;REEL/FRAME:022549/0001;SIGNING DATES FROM 20090403 TO 20090413 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |